nivolumab/therapeutic use	immune checkpoint inhibitors	0.5296052631578947	36096534
nephritis/chemically induced	nivolumab/therapeutic use	0.020833333333333332	32130969
gene expression regulation/genetics	cd8-positive t-lymphocytes/cytology	0.010416666666666668	32603654
nivolumab/therapeutic use	glucocorticoids	0.020833333333333336	36096534
gene expression regulation/genetics	inflammation/drug therapy	0.020833333333333332	32603654
nivolumab/therapeutic use	pruritus/chemically induced	0.020833333333333336	32130969
diarrhea	neoplasms	0.08201754385964914	35842365
gene expression regulation/genetics	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32603654
gene expression regulation/genetics	myeloid cells/cytology	0.010416666666666668	32603654
gene expression regulation/genetics	ctla-4 antigen/immunology	0.010416666666666668	32603654
nephritis/chemically induced	diabetes mellitus type 1/chemically induced	0.010416666666666668	32130969
nivolumab/therapeutic use	adrenal insufficiency/chemically induced	0.020833333333333336	32130969
adrenal gland diseases/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
nivolumab/therapeutic use	axitinib/administration & dosage	0.020833333333333336	32130969
nephritis/chemically induced	exanthema/chemically induced	0.010416666666666668	32130969
nephritis/chemically induced	bevacizumab/administration & dosage	0.010416666666666668	32130969
diarrhea	immune checkpoint inhibitors	0.09539473684210525	35842365
diarrhea	immune checkpoint inhibitors	0.09539473684210525	32780983
nivolumab/therapeutic use	diarrhea/chemically induced	0.2894736842105262	36096534
nephritis/chemically induced	pneumonia/chemically induced	0.03125	32130969
nephritis/chemically induced	fatigue/chemically induced	0.010416666666666668	32130969
diarrhea	colitis	0.0013157894736842107	35842365
diarrhea	colitis	0.0013157894736842107	32780983
colitis ulcerative	immune checkpoint inhibitors	0.3125	33146440
nivolumab/therapeutic use	colitis/chemically induced	0.5296052631578946	32130969
nivolumab/therapeutic use	colitis/chemically induced	0.5296052631578946	36096534
nivolumab/therapeutic use	hypophysitis/chemically induced	0.020833333333333336	32130969
nephritis/chemically induced	pruritus/chemically induced	0.010416666666666668	32130969
gene expression regulation/genetics	colitis/drug therapy	0.03125	32603654
nivolumab/therapeutic use	angiogenesis inhibitors/therapeutic use	0.020833333333333336	32130969
diarrhea	recurrence	0.0618421052631579	35842365
nephritis/chemically induced	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
nivolumab/therapeutic use	myocarditis/chemically induced	0.020833333333333336	32130969
nephritis/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
nivolumab/therapeutic use	hepatitis autoimmune/etiology	0.020833333333333336	32130969
gene expression regulation/genetics	receptors antigen t-cell/genetics	0.010416666666666668	32603654
nivolumab/therapeutic use	myasthenia gravis/chemically induced	0.020833333333333336	32130969
nephritis/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
nivolumab/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.041447368421052636	32130969
diarrhea	inflammatory bowel diseases	0.041447368421052636	35842365
nephritis/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
gene expression regulation/genetics	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
nephritis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
nephritis/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
nephritis/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
nephritis/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
nivolumab/therapeutic use	ipilimumab/therapeutic use	0.0618421052631579	32130969
nephritis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
gene expression regulation/genetics	chemokines/metabolism	0.010416666666666668	32603654
myeloid-derived suppressor cells/metabolism	azoxymethane/adverse effects	0.010416666666666668	33495297
gene expression regulation/genetics	multigene family	0.010416666666666668	32603654
nephritis/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
nivolumab/therapeutic use	CHI3L1	0.020833333333333336	36096534
nivolumab/therapeutic use	CXCL8	0.020833333333333336	36096534
nivolumab/therapeutic use	IL17A	0.041447368421052636	36096534
myeloid-derived suppressor cells/metabolism	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33495297
nivolumab/therapeutic use	IL6	0.041447368421052636	36096534
myeloid-derived suppressor cells/metabolism	colitis/chemically induced	0.7291666666666666	33495297
myeloid-derived suppressor cells/metabolism	phthalazines/administration & dosage	0.010416666666666668	33495297
myeloid-derived suppressor cells/metabolism	dextran sulfate/adverse effects	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	nephritis/chemically induced	0.020833333333333336	32130969
gene expression regulation/genetics	CTLA4	0.125	32603654
carcinoma renal cell/drug therapy	nivolumab/therapeutic use	0.041447368421052636	32130969
myeloid-derived suppressor cells/metabolism	colonic neoplasms/drug therapy	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	diabetes mellitus type 1/chemically induced	0.020833333333333336	32130969
hashimoto disease/chemically induced	nivolumab/adverse effects	0.125	33476895
gene expression regulation/genetics	PDCD1	0.26041666666666663	32603654
sirolimus/therapeutic use	drug-related side effects and adverse reactions/prevention & control	0.010416666666666668	34987517
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/adverse effects	0.8019736842105263	35277350
carcinoma renal cell/drug therapy	exanthema/chemically induced	0.020833333333333336	32130969
carcinoma renal cell/drug therapy	bevacizumab/administration & dosage	0.020833333333333336	32130969
hashimoto disease/chemically induced	immune checkpoint inhibitors/adverse effects	0.5520833333333333	33476895
carcinoma renal cell/drug therapy	pneumonia/chemically induced	0.0618421052631579	32130969
carcinoma renal cell/drug therapy	fatigue/chemically induced	0.020833333333333336	32130969
myeloid-derived suppressor cells/metabolism	cell line tumor	0.020833333333333332	33495297
carcinoma renal cell/drug therapy	pruritus/chemically induced	0.020833333333333336	32130969
myeloid-derived suppressor cells/metabolism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	adrenal insufficiency/chemically induced	0.020833333333333336	32130969
hashimoto disease/chemically induced	squamous cell carcinoma of head and neck/drug therapy	0.010416666666666668	33476895
hashimoto disease/chemically induced	tongue neoplasms/drug therapy	0.010416666666666668	33476895
carcinoma renal cell/drug therapy	axitinib/administration & dosage	0.020833333333333336	32130969
carcinoma renal cell/drug therapy	inflammatory bowel diseases/drug therapy	0.0618421052631579	35277350
ulcer/chemically induced	immune checkpoint inhibitors	0.3125	33746162
myeloid-derived suppressor cells/metabolism	piperazines/administration & dosage	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	proton pump inhibitors/adverse effects	0.020833333333333336	35277350
myeloid-derived suppressor cells/metabolism	APC	0.020833333333333332	33495297
myeloid-derived suppressor cells/metabolism	ARG1	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5296052631578946	32130969
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5296052631578946	35277350
intestinal mucosa/diagnostic imaging	colon/diagnostic imaging	0.010416666666666668	32414860
intestinal mucosa/diagnostic imaging	drug resistance/immunology	0.010416666666666668	32414860
carcinoma renal cell/drug therapy	hypophysitis/chemically induced	0.020833333333333336	32130969
hashimoto disease/chemically induced	paclitaxel/therapeutic use	0.010416666666666668	33476895
carcinoma renal cell/drug therapy	angiogenesis inhibitors/therapeutic use	0.020833333333333336	32130969
intestinal mucosa/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32414860
carcinoma renal cell/drug therapy	myocarditis/chemically induced	0.020833333333333336	32130969
sirolimus/therapeutic use	growth inhibitors/therapeutic use	0.010416666666666668	34987517
myeloid-derived suppressor cells/metabolism	PARP1	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	hepatitis autoimmune/etiology	0.020833333333333336	32130969
myeloid-derived suppressor cells/metabolism	PDCD1	0.26041666666666663	33495297
hashimoto disease/chemically induced	colitis ulcerative/chemically induced	0.010416666666666668	33476895
myeloid-derived suppressor cells/metabolism	TIPARP	0.010416666666666668	33495297
carcinoma renal cell/drug therapy	myasthenia gravis/chemically induced	0.020833333333333336	32130969
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/therapeutic use	0.041447368421052636	32130969
intestinal mucosa/diagnostic imaging	skin neoplasms/drug therapy	0.020833333333333332	32414860
ulcer/chemically induced	colitis/chemically induced	0.7291666666666666	33746162
intestinal mucosa/diagnostic imaging	infliximab/adverse effects	0.041666666666666664	32414860
hashimoto disease/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33476895
esophagitis	ulcer/chemically induced	0.010416666666666668	33746162
sirolimus/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010416666666666668	34987517
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0006578947368421054	32130969
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0006578947368421054	35277350
sirolimus/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03125	34987517
sirolimus/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010416666666666668	34987517
hashimoto disease/chemically induced	antineoplastic agents immunological/adverse effects	0.07291666666666667	33476895
sirolimus/therapeutic use	colitis/etiology	0.020833333333333332	34987517
sirolimus/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	34987517
sirolimus/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34987517
sirolimus/therapeutic use	cell line tumor	0.020833333333333332	34987517
intestinal mucosa/diagnostic imaging	colitis/chemically induced	0.7291666666666666	32414860
esophagitis	immune checkpoint inhibitors	0.3125	33746162
intestinal mucosa/diagnostic imaging	glucocorticoids/pharmacology	0.010416666666666668	32414860
hashimoto disease/chemically induced	SNCA	0.03125	33476895
sirolimus/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010416666666666668	34987517
prednisolone/therapeutic use	nivolumab/adverse effects	0.125	34716545
intestinal mucosa/diagnostic imaging	melanoma/drug therapy	0.05208333333333334	32414860
sirolimus/therapeutic use	cytotoxicity immunologic	0.010416666666666668	34987517
sirolimus/therapeutic use	CD8A	0.05208333333333334	34987517
intestinal mucosa/diagnostic imaging	immunosuppressive agents/pharmacology	0.010416666666666668	32414860
prednisolone/therapeutic use	immune checkpoint inhibitors	0.3125	34716545
esophagitis	colitis/chemically induced	0.7291666666666666	33746162
prednisolone/therapeutic use	lung neoplasms/drug therapy	0.020833333333333332	34716545
intestinal mucosa/diagnostic imaging	mucositis/chemically induced	0.010416666666666668	32414860
sirolimus/therapeutic use	MTOR	0.010416666666666668	34987517
sirolimus/therapeutic use	PDCD1	0.26041666666666663	34987517
psoriasis	immune checkpoint inhibitors	0.3125	35977003
prednisolone/therapeutic use	colitis/chemically induced	0.7291666666666666	34716545
psoriasis	colitis/chemically induced	0.7291666666666666	35977003
vitamin d	immune checkpoint inhibitors/adverse effects	0.5520833333333333	36338892
colitis ulcerative/immunology	pyrimidines/therapeutic use	0.041447368421052636	34147519
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3021929824561404	34338882
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3021929824561404	34147519
psoriasis	dermatitis	0.010416666666666668	35977003
colitis ulcerative/immunology	macrophages/drug effects	0.020833333333333336	34338882
colitis ulcerative/immunology	interferon-gamma/metabolism	0.020833333333333336	34147519
colitis ulcerative/immunology	immunologic memory/drug effects	0.020833333333333336	34147519
colitis ulcerative/immunology	colon/drug effects	0.0006578947368421054	34338882
colitis ulcerative/immunology	colon/drug effects	0.0006578947368421054	34147519
melanoma/genetics	receptors cxcr6/genetics	0.010416666666666668	32603654
melanoma/genetics	gene expression regulation/genetics	0.010416666666666668	32603654
psoriasis	rna	0.010416666666666668	35977003
melanoma/genetics	receptors cxcr3/genetics	0.010416666666666668	32603654
vitamin d	colitis/chemically induced	0.7291666666666666	36338892
melanoma/genetics	cd8-positive t-lymphocytes/cytology	0.010416666666666668	32603654
psoriasis	CTLA4	0.125	35977003
psoriasis	CXCL10	0.010416666666666668	35977003
melanoma/genetics	inflammation/drug therapy	0.020833333333333332	32603654
psoriasis	CXCL9	0.010416666666666668	35977003
melanoma/genetics	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32603654
melanoma/genetics	myeloid cells/cytology	0.010416666666666668	32603654
colitis ulcerative/immunology	crohn disease/immunology	0.020833333333333336	34338882
psoriasis	PDCD1	0.26041666666666663	35977003
melanoma/genetics	ctla-4 antigen/immunology	0.010416666666666668	32603654
psoriasis	TCIM	0.010416666666666668	35977003
psoriasis	TNF	0.03125	35977003
vitamin d	melanoma/drug therapy	0.05208333333333334	36338892
drug synergism	sirolimus/therapeutic use	0.020833333333333336	34987517
carcinoma non-small-cell lung	immune checkpoint inhibitors	0.3125	34106395
drug synergism	myeloid-derived suppressor cells/metabolism	0.020833333333333336	33495297
colitis ulcerative/immunology	piperidines/therapeutic use	0.041447368421052636	34147519
drug synergism	drug-related side effects and adverse reactions/prevention & control	0.020833333333333336	34987517
colitis ulcerative/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34147519
melanoma/genetics	colitis/drug therapy	0.03125	32603654
colitis ulcerative/immunology	ctla-4 antigen/antagonists & inhibitors	0.0618421052631579	34147519
carcinoma non-small-cell lung	colitis/chemically induced	0.7291666666666666	34106395
vitamin d	antineoplastic agents immunological/adverse effects	0.07291666666666667	36338892
colitis ulcerative/immunology	graft vs host disease/immunology	0.020833333333333336	34338882
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.0002192982456140351	34338882
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.0002192982456140351	34147519
drug synergism	azoxymethane/adverse effects	0.020833333333333336	33495297
colitis ulcerative/immunology	phenotype	0.0002192982456140351	34338882
colitis ulcerative/immunology	phenotype	0.0002192982456140351	34147519
melanoma/genetics	receptors antigen t-cell/genetics	0.010416666666666668	32603654
urothelium/drug effects	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	32418993
urothelium/drug effects	colitis/chemically induced	0.7291666666666666	32418993
melanoma/genetics	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
drug synergism	immune checkpoint inhibitors/administration & dosage	0.08201754385964914	33495297
colitis ulcerative/immunology	CD4	0.041447368421052636	34338882
colitis ulcerative/immunology	CD68	0.041447368421052636	34338882
drug synergism	growth inhibitors/therapeutic use	0.020833333333333336	34987517
colitis ulcerative/immunology	CD8A	0.002192982456140351	34338882
colitis ulcerative/immunology	CD8A	0.002192982456140351	34147519
carcinoma non-small-cell lung	cd8-positive t-lymphocytes	0.010416666666666668	34106395
drug synergism	colitis/chemically induced	0.9287280701754386	33495297
colitis ulcerative/immunology	CTLA4	0.23552631578947367	34147519
drug synergism	phthalazines/administration & dosage	0.020833333333333336	33495297
drug synergism	dextran sulfate/adverse effects	0.020833333333333336	33495297
urothelium/drug effects	carcinoma non-small-cell lung/complications	0.010416666666666668	32418993
colitis ulcerative/immunology	PDCD1	0.45504385964912286	34147519
drug synergism	colonic neoplasms/drug therapy	0.020833333333333336	33495297
melanoma/genetics	chemokines/metabolism	0.010416666666666668	32603654
drug synergism	phosphatidylinositol 3-kinases/metabolism	0.020833333333333336	34987517
melanoma/genetics	multigene family	0.010416666666666668	32603654
drug synergism	antineoplastic agents immunological/therapeutic use	0.0618421052631579	34987517
receptors cxcr3/genetics	cd8-positive t-lymphocytes/cytology	0.010416666666666668	32603654
drug synergism	lymphocytes tumor-infiltrating/immunology	0.020833333333333336	34987517
receptors cxcr3/genetics	inflammation/drug therapy	0.020833333333333332	32603654
urothelium/drug effects	drug-related side effects and adverse reactions	0.020833333333333332	32418993
receptors cxcr3/genetics	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32603654
urothelium/drug effects	melanoma/complications	0.03125	32418993
receptors cxcr3/genetics	myeloid cells/cytology	0.010416666666666668	32603654
drug synergism	colitis/etiology	0.041447368421052636	34987517
drug synergism	immune checkpoint inhibitors/therapeutic use	0.041447368421052636	34987517
receptors cxcr6/genetics	gene expression regulation/genetics	0.010416666666666668	32603654
receptors cxcr3/genetics	ctla-4 antigen/immunology	0.010416666666666668	32603654
drug synergism	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34987517
receptors cxcr6/genetics	receptors cxcr3/genetics	0.010416666666666668	32603654
urothelium/drug effects	infliximab/administration & dosage	0.010416666666666668	32418993
drug synergism	cell line tumor	0.0002192982456140351	33495297
drug synergism	cell line tumor	0.0002192982456140351	34987517
receptors cxcr6/genetics	cd8-positive t-lymphocytes/cytology	0.010416666666666668	32603654
drug synergism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.020833333333333336	33495297
thyroiditis/diagnostic imaging	adrenal gland diseases/diagnostic imaging	0.010416666666666668	33375984
receptors cxcr6/genetics	inflammation/drug therapy	0.020833333333333332	32603654
receptors cxcr6/genetics	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32603654
drug synergism	cd8-positive t-lymphocytes/immunology	0.020833333333333336	34987517
melanoma/genetics	CTLA4	0.125	32603654
receptors cxcr6/genetics	myeloid cells/cytology	0.010416666666666668	32603654
thyroiditis/diagnostic imaging	myocarditis/diagnostic imaging	0.010416666666666668	33375984
receptors cxcr6/genetics	ctla-4 antigen/immunology	0.010416666666666668	32603654
thyroiditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5520833333333333	33375984
urothelium/drug effects	ACAD8	0.020833333333333332	32418993
drug synergism	piperazines/administration & dosage	0.020833333333333336	33495297
drug synergism	cytotoxicity immunologic	0.020833333333333336	34987517
melanoma/genetics	PDCD1	0.26041666666666663	32603654
thyroiditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010416666666666668	33375984
thyroiditis/diagnostic imaging	neoplasms/diagnostic imaging	0.020833333333333332	33375984
drug synergism	APC	0.041447368421052636	33495297
urothelium/drug effects	CRP	0.010416666666666668	32418993
drug synergism	ARG1	0.020833333333333336	33495297
receptors cxcr3/genetics	colitis/drug therapy	0.03125	32603654
drug synergism	CD8A	0.10197368421052633	34987517
thyroiditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010416666666666668	33375984
thyroiditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010416666666666668	33375984
drug synergism	MTOR	0.020833333333333336	34987517
drug synergism	PARP1	0.020833333333333336	33495297
drug synergism	PDCD1	0.06578947368421052	33495297
drug synergism	PDCD1	0.06578947368421052	34987517
drug synergism	TIPARP	0.020833333333333336	33495297
receptors cxcr3/genetics	receptors antigen t-cell/genetics	0.010416666666666668	32603654
receptors cxcr6/genetics	colitis/drug therapy	0.03125	32603654
thyroiditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
thyroiditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
receptors cxcr3/genetics	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
host microbial interactions/drug effects	metabolome/drug effects	0.010416666666666668	34162429
thyroiditis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
immune system diseases/drug therapy	immune checkpoint inhibitors/adverse effects	0.5520833333333333	36159840
host microbial interactions/drug effects	immune checkpoint inhibitors/adverse effects	0.5520833333333333	34162429
receptors cxcr6/genetics	receptors antigen t-cell/genetics	0.010416666666666668	32603654
receptors cxcr6/genetics	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
receptors cxcr3/genetics	chemokines/metabolism	0.010416666666666668	32603654
receptors cxcr3/genetics	multigene family	0.010416666666666668	32603654
protective agents/pharmacology	mesalamine/pharmacology	0.010416666666666668	33506015
thyroiditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
protective agents/pharmacology	colon/drug effects	0.03125	33506015
receptors cxcr6/genetics	chemokines/metabolism	0.010416666666666668	32603654
receptors cxcr6/genetics	multigene family	0.010416666666666668	32603654
protective agents/pharmacology	colitis/chemically induced	0.7291666666666666	33506015
receptors cxcr3/genetics	CTLA4	0.125	32603654
host microbial interactions/drug effects	dysbiosis/etiology	0.010416666666666668	34162429
immune system diseases/drug therapy	colitis/chemically induced	0.7291666666666666	36159840
host microbial interactions/drug effects	neoplasms/complications	0.03125	34162429
receptors cxcr3/genetics	PDCD1	0.26041666666666663	32603654
protective agents/pharmacology	immune checkpoint inhibitors/pharmacology	0.041666666666666664	33506015
receptors cxcr6/genetics	CTLA4	0.125	32603654
protective agents/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33506015
neoplasms	immune checkpoint inhibitors/adverse effects	0.7659565437271971	36389768
neoplasms	immune checkpoint inhibitors/adverse effects	0.7659565437271971	36189293
immune system diseases/drug therapy	antineoplastic agents immunological/therapeutic use	0.03125	36159840
protective agents/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010416666666666668	33506015
neoplasms	immune checkpoint inhibitors	0.36979373622800993	35842365
neoplasms	immune checkpoint inhibitors	0.36979373622800993	32584703
receptors cxcr6/genetics	PDCD1	0.26041666666666663	32603654
pneumonia	immune checkpoint inhibitors/adverse effects	0.5520833333333333	35432346
host microbial interactions/drug effects	colitis/etiology	0.020833333333333332	34162429
immune system diseases/drug therapy	gastrointestinal neoplasms/drug therapy	0.010416666666666668	36159840
neoplasms	infliximab/adverse effects	0.15888361088032368	32584703
neoplasms	colitis	0.15888361088032368	35842365
protective agents/pharmacology	ACAD8	0.020833333333333332	33506015
host microbial interactions/drug effects	antineoplastic agents immunological/adverse effects	0.07291666666666667	34162429
neoplasms	recurrence	0.12108062709966406	35842365
neoplasms	diarrhea/chemically induced	0.49916916519163396	32584703
pneumonia	colitis	0.041666666666666664	35432346
protective agents/pharmacology	PDCD1	0.26041666666666663	33506015
neoplasms	colitis/chemically induced	0.7044440631434454	36389768
neoplasms	colitis/chemically induced	0.7044440631434454	36189293
neoplasms	colitis/chemically induced	0.7044440631434454	32584703
adrenal cortex hormones/therapeutic use	inflammation/drug therapy	0.08201754385964913	36113896
host microbial interactions/drug effects	anti-bacterial agents/pharmacology	0.010416666666666668	34162429
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors/adverse effects	0.9628502450360631	34380976
immune system diseases/drug therapy	BTLA	0.010416666666666668	36159840
immune system diseases/drug therapy	CD274	0.15624999999999997	36159840
immune system diseases/drug therapy	CD28	0.010416666666666668	36159840
immune system diseases/drug therapy	CSF2	0.010416666666666668	36159840
immune system diseases/drug therapy	HAVCR2	0.010416666666666668	36159840
immune system diseases/drug therapy	IL15	0.010416666666666668	36159840
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.36979373622800993	36113896
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.36979373622800993	32641348
immune system diseases/drug therapy	IL17C	0.010416666666666668	36159840
neoplasms	inflammatory bowel diseases	0.08201754385964913	35842365
immune system diseases/drug therapy	IL21	0.010416666666666668	36159840
immune system diseases/drug therapy	IL22	0.020833333333333332	36159840
interleukin-17/genetics	micrornas/genetics	0.010416666666666668	33462141
immune system diseases/drug therapy	IL4	0.010416666666666668	36159840
immune system diseases/drug therapy	IL6	0.020833333333333332	36159840
adrenal cortex hormones/therapeutic use	skin neoplasms/drug therapy	0.08201754385964913	32641348
immune system diseases/drug therapy	LIF	0.010416666666666668	36159840
adrenal cortex hormones/therapeutic use	tumor necrosis factor inhibitors	0.041666666666666664	32641348
immune system diseases/drug therapy	PDCD1	0.26041666666666663	36159840
interleukin-17/genetics	gene expression regulation neoplastic	0.010416666666666668	33462141
interleukin-17/genetics	lymphocytes tumor-infiltrating/metabolism	0.010416666666666668	33462141
adrenal cortex hormones/therapeutic use	neoplasms/drug therapy	0.4191679008777951	34380976
adrenal cortex hormones/therapeutic use	recurrence	0.12108062709966406	26448188
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00041090199761586543	36113896
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00041090199761586543	26448188
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00041090199761586543	34380976
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00041090199761586543	32641348
interleukin-17/genetics	t-lymphocytes cytotoxic/immunology	0.010416666666666668	33462141
interleukin-17/genetics	tumor microenvironment/drug effects	0.010416666666666668	33462141
pneumonia	ligands	0.010416666666666668	35432346
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.27601024696263654	36113896
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.27601024696263654	26448188
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.27601024696263654	34380976
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.27601024696263654	32641348
neoplasms	LTF	0.041666666666666664	32584703
interleukin-17/genetics	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
glucocorticoids/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5520833333333333	36377339
interleukin-17/genetics	ht29 cells	0.010416666666666668	33462141
interleukin-17/genetics	colitis/chemically induced	0.7291666666666666	33462141
interleukin-17/genetics	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
adrenal cortex hormones/therapeutic use	melanoma/drug therapy	0.19545388866813576	32641348
interleukin-17/genetics	b7-h1 antigen/genetics	0.010416666666666668	33462141
pneumonia	CD274	0.15624999999999997	35432346
glucocorticoids/therapeutic use	disease progression	0.010416666666666668	36377339
pneumonia	CTLA4	0.125	35432346
drug-related side effects and adverse reactions/prevention & control	growth inhibitors/therapeutic use	0.010416666666666668	34987517
adrenal cortex hormones/therapeutic use	biological products/therapeutic use	0.041666666666666664	34380976
pneumonia	PDCD1	0.26041666666666663	35432346
glucocorticoids/therapeutic use	neoplasms/drug therapy	0.125	36377339
diabetes mellitus type 1/chemically induced	exanthema/chemically induced	0.010416666666666668	32130969
adrenal cortex hormones/therapeutic use	beclomethasone/adverse effects	0.041666666666666664	36113896
diabetes mellitus type 1/chemically induced	bevacizumab/administration & dosage	0.010416666666666668	32130969
glucocorticoids/therapeutic use	diarrhea/chemically induced	0.15624999999999997	36377339
diabetes mellitus type 1/chemically induced	pneumonia/chemically induced	0.03125	32130969
adrenal cortex hormones/therapeutic use	biomarkers/analysis	0.12108062709966406	26448188
diabetes mellitus type 1/chemically induced	fatigue/chemically induced	0.010416666666666668	32130969
glucocorticoids/therapeutic use	colitis/chemically induced	0.7291666666666666	36377339
interleukin-17/genetics	APC	0.020833333333333332	33462141
glucocorticoids/therapeutic use	abdominal pain/chemically induced	0.010416666666666668	36377339
diabetes mellitus type 1/chemically induced	pruritus/chemically induced	0.010416666666666668	32130969
drug-related side effects and adverse reactions/prevention & control	phosphatidylinositol 3-kinases/metabolism	0.010416666666666668	34987517
ustekinumab/therapeutic use	colitis ulcerative/drug therapy	0.041666666666666664	33567198
interleukin-17/genetics	CD274	0.15624999999999997	33462141
drug-related side effects and adverse reactions/prevention & control	antineoplastic agents immunological/therapeutic use	0.03125	34987517
ustekinumab/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5520833333333333	33567198
interleukin-17/genetics	CD8A	0.05208333333333334	33462141
diabetes mellitus type 1/chemically induced	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
drug-related side effects and adverse reactions/prevention & control	lymphocytes tumor-infiltrating/immunology	0.010416666666666668	34987517
drug-related side effects and adverse reactions/prevention & control	colitis/etiology	0.020833333333333332	34987517
diabetes mellitus type 1/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
drug-related side effects and adverse reactions/prevention & control	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	34987517
drug-related side effects and adverse reactions/prevention & control	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34987517
glucocorticoids/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03125	36377339
adrenal cortex hormones/therapeutic use	SNCA	0.12108062709966406	32641348
adrenal cortex hormones/therapeutic use	TNF	0.12108062709966406	32641348
drug-related side effects and adverse reactions/prevention & control	cell line tumor	0.020833333333333332	34987517
adrenal cortex hormones/therapeutic use	antineoplastic agents/adverse effects	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	intestinal mucosa/chemistry	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	leukemia lymphocytic chronic b-cell/drug therapy	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	purines/adverse effects	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	colon/chemistry	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	lymphocytosis/chemically induced	0.041666666666666664	26448188
diabetes mellitus type 1/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
adrenal cortex hormones/therapeutic use	protein kinase inhibitors/adverse effects	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	apoptosis/drug effects	0.041666666666666664	26448188
diabetes mellitus type 1/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
adrenal cortex hormones/therapeutic use	quinazolinones/adverse effects	0.041666666666666664	26448188
interleukin-17/genetics	IL17A	0.020833333333333332	33462141
drug-related side effects and adverse reactions/prevention & control	cd8-positive t-lymphocytes/immunology	0.010416666666666668	34987517
adrenal cortex hormones/therapeutic use	lymphoma non-hodgkin/drug therapy	0.041666666666666664	26448188
adrenal cortex hormones/therapeutic use	PIK3CD	0.041666666666666664	26448188
diabetes mellitus type 1/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
interleukin-17/genetics	MIR15B	0.010416666666666668	33462141
glucocorticoids/therapeutic use	gastritis/complications	0.010416666666666668	36377339
diabetes mellitus type 1/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
interleukin-17/genetics	NRF1	0.010416666666666668	33462141
interleukin-17/genetics	PDCD1	0.26041666666666663	33462141
glucocorticoids/therapeutic use	enterocolitis/chemically induced	0.020833333333333332	36377339
drug-related side effects and adverse reactions/prevention & control	cytotoxicity immunologic	0.010416666666666668	34987517
diabetes mellitus type 1/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
diabetes mellitus type 1/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
diabetes mellitus type 1/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
drug-related side effects and adverse reactions/prevention & control	CD8A	0.05208333333333334	34987517
ustekinumab/therapeutic use	interleukin-23/antagonists & inhibitors	0.010416666666666668	33567198
nivolumab/therapeutic use	diabetes mellitus type 1/chemically induced	0.020833333333333336	32130969
diabetes mellitus type 1/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
drug-related side effects and adverse reactions/prevention & control	MTOR	0.010416666666666668	34987517
drug-related side effects and adverse reactions/prevention & control	PDCD1	0.26041666666666663	34987517
colitis/therapy	immune checkpoint inhibitors	0.3125	33566423
nivolumab/therapeutic use	exanthema/chemically induced	0.020833333333333336	32130969
nivolumab/therapeutic use	bevacizumab/administration & dosage	0.020833333333333336	32130969
nivolumab/therapeutic use	arthritis/chemically induced	0.020833333333333336	36096534
nivolumab/therapeutic use	pneumonia/chemically induced	0.0618421052631579	32130969
nivolumab/therapeutic use	fatigue/chemically induced	0.020833333333333336	32130969
cd8-positive t-lymphocytes/cytology	chemokines/metabolism	0.010416666666666668	32603654
cd8-positive t-lymphocytes/cytology	multigene family	0.010416666666666668	32603654
nivolumab/adverse effects	pyrimidines/therapeutic use	0.23552631578947367	33096100
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	34159488
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	33096100
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	33882697
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	33906378
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	34332139
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	31595568
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	32931028
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	32028372
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.12141258208575266	33476895
colitis/therapy	immunologic factors	0.020833333333333332	33566423
nivolumab/adverse effects	pneumonia/chemically induced	0.3331187010078388	35124713
ustekinumab/therapeutic use	interleukin-12/antagonists & inhibitors	0.010416666666666668	33567198
nivolumab/adverse effects	colitis/diagnosis	0.23552631578947367	32028372
nivolumab/adverse effects	immune checkpoint inhibitors	0.7936155410859613	35191192
nivolumab/adverse effects	immune checkpoint inhibitors	0.7936155410859613	34716545
nivolumab/adverse effects	immune checkpoint inhibitors	0.7936155410859613	35124713
cd8-positive t-lymphocytes/cytology	CTLA4	0.125	32603654
micrornas/genetics	gene expression regulation neoplastic	0.010416666666666668	33462141
escherichia coli infections/drug therapy	virus diseases/etiology	0.010416666666666668	34107499
micrornas/genetics	lymphocytes tumor-infiltrating/metabolism	0.010416666666666668	33462141
nivolumab/adverse effects	lung neoplasms/drug therapy	0.23552631578947367	34716545
cd8-positive t-lymphocytes/cytology	PDCD1	0.26041666666666663	32603654
escherichia coli infections/drug therapy	immune checkpoint inhibitors/adverse effects	0.5520833333333333	34107499
nivolumab/adverse effects	protein kinase inhibitors/therapeutic use	0.12500000000000003	33096100
nivolumab/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.12500000000000003	33476895
nivolumab/adverse effects	tongue neoplasms/drug therapy	0.12500000000000003	33476895
nivolumab/adverse effects	carcinoma non-small-cell lung/drug therapy	0.23552631578947367	35124713
micrornas/genetics	t-lymphocytes cytotoxic/immunology	0.010416666666666668	33462141
micrornas/genetics	tumor microenvironment/drug effects	0.010416666666666668	33462141
nivolumab/adverse effects	neoplasms/drug therapy	0.819115475148472	33096100
micrornas/genetics	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
nivolumab/adverse effects	diarrhea/chemically induced	0.8867810643744477	31595568
micrornas/genetics	ht29 cells	0.010416666666666668	33462141
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	34159488
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	33096100
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	33882697
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	34332139
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	31595568
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	32931028
nivolumab/adverse effects	ipilimumab/adverse effects	2.161680263935751e-06	35191192
micrornas/genetics	colitis/chemically induced	0.7291666666666666	33462141
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	34159488
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	34716545
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	33096100
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	35124713
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	33906378
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	34332139
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	33882697
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	31595568
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	32931028
nivolumab/adverse effects	colitis/chemically induced	0.31349064396220855	35191192
micrornas/genetics	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
micrornas/genetics	b7-h1 antigen/genetics	0.010416666666666668	33462141
nivolumab/adverse effects	paclitaxel/therapeutic use	0.12500000000000003	33476895
virus diseases/etiology	immune checkpoint inhibitors/adverse effects	0.5520833333333333	34107499
escherichia coli infections/drug therapy	neoplasms/drug therapy	0.125	34107499
tryptophan/pharmacology	neoplasms/drug therapy	0.125	35236743
escherichia coli infections/drug therapy	diarrhea/chemically induced	0.15624999999999997	34107499
nivolumab/adverse effects	oropharyngeal neoplasms/drug therapy	0.12500000000000003	33906378
escherichia coli infections/drug therapy	clostridium infections/chemically induced	0.010416666666666668	34107499
nivolumab/adverse effects	disease susceptibility	0.12500000000000003	32028372
tryptophan/pharmacology	colitis/chemically induced	0.7291666666666666	35236743
nivolumab/adverse effects	colitis ulcerative/chemically induced	0.12500000000000003	33476895
escherichia coli infections/drug therapy	colitis/chemically induced	0.7291666666666666	34107499
nivolumab/adverse effects	melanoma/drug therapy	0.49492860945895223	33882697
nivolumab/adverse effects	piperidines/therapeutic use	0.23552631578947367	33096100
nivolumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.12500000000000003	35191192
escherichia coli infections/drug therapy	anti-bacterial agents/adverse effects	0.010416666666666668	34107499
tryptophan/pharmacology	immune checkpoint inhibitors/pharmacology	0.041666666666666664	35236743
nivolumab/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.6712306828612955	33476895
nivolumab/adverse effects	postoperative complications	0.12500000000000003	32028372
virus diseases/etiology	neoplasms/drug therapy	0.125	34107499
micrornas/genetics	APC	0.020833333333333332	33462141
micrornas/genetics	CD274	0.15624999999999997	33462141
virus diseases/etiology	diarrhea/chemically induced	0.15624999999999997	34107499
micrornas/genetics	CD8A	0.05208333333333334	33462141
micrornas/genetics	IL17A	0.020833333333333332	33462141
nivolumab/adverse effects	antineoplastic agents immunological/adverse effects	0.6199939061643546	33476895
virus diseases/etiology	clostridium infections/chemically induced	0.010416666666666668	34107499
nivolumab/adverse effects	ipilimumab/therapeutic use	0.3331187010078388	35124713
micrornas/genetics	MIR15B	0.010416666666666668	33462141
virus diseases/etiology	colitis/chemically induced	0.7291666666666666	34107499
micrornas/genetics	NRF1	0.010416666666666668	33462141
micrornas/genetics	PDCD1	0.26041666666666663	33462141
adrenal gland diseases/diagnostic imaging	myocarditis/diagnostic imaging	0.010416666666666668	33375984
adrenal gland diseases/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5520833333333333	33375984
tryptophan/pharmacology	AHR	0.010416666666666668	35236743
virus diseases/etiology	anti-bacterial agents/adverse effects	0.010416666666666668	34107499
adrenal gland diseases/diagnostic imaging	pancreatitis/diagnostic imaging	0.010416666666666668	33375984
metabolome/drug effects	immune checkpoint inhibitors/adverse effects	0.5520833333333333	34162429
adrenal gland diseases/diagnostic imaging	neoplasms/diagnostic imaging	0.020833333333333332	33375984
nivolumab/adverse effects	CTLA4	0.819115475148472	35191192
tryptophan/pharmacology	IL22	0.020833333333333332	35236743
nivolumab/adverse effects	PDCD1	0.8770285319264266	35191192
nivolumab/adverse effects	PDCD1	0.8770285319264266	33906378
nivolumab/adverse effects	SNCA	0.3331187010078388	33476895
adrenal gland diseases/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010416666666666668	33375984
adrenal gland diseases/diagnostic imaging	hepatitis/diagnostic imaging	0.010416666666666668	33375984
inflammation/drug therapy	immune checkpoint inhibitors/adverse effects	0.8019736842105263	32603654
inflammation/drug therapy	myeloid cells/cytology	0.020833333333333336	32603654
inflammation/drug therapy	ctla-4 antigen/immunology	0.020833333333333336	32603654
gene expression regulation/genetics	receptors cxcr3/genetics	0.010416666666666668	32603654
immune checkpoint inhibitors/adverse effects	hepatitis/diagnosis	0.5520833333333333	32185493
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	32422528
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	32702598
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	32567084
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	36338892
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	32434876
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	34162429
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.012932342544064696	33476895
adrenal gland diseases/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
inflammation/drug therapy	immune checkpoint inhibitors	0.5296052631578947	36113896
immune checkpoint inhibitors/adverse effects	ipilimumab/therapeutic use	0.9136268197088466	35277350
adrenal gland diseases/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
immune checkpoint inhibitors/adverse effects	pneumonia/diagnostic imaging	0.5520833333333333	33375984
immune checkpoint inhibitors/adverse effects	interleukin-12/antagonists & inhibitors	0.5520833333333333	33567198
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.30219298245614035	34338882
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.30219298245614035	34147519
immune checkpoint inhibitors/adverse effects	biomarkers/analysis	0.9136268197088466	33436487
metabolome/drug effects	dysbiosis/etiology	0.010416666666666668	34162429
immune checkpoint inhibitors/adverse effects	phenotype	0.30219298245614035	34338882
immune checkpoint inhibitors/adverse effects	phenotype	0.30219298245614035	34147519
immune checkpoint inhibitors/adverse effects	butyrates/metabolism	0.5520833333333333	33741313
colitis/diagnosis	postoperative complications	0.020833333333333336	32028372
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/complications	0.8019736842105263	34158318
myasthenia gravis/diagnosis	immunosuppressive agents/therapeutic use	0.010416666666666668	34956219
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/pharmacology	0.5520833333333333	34162429
metabolome/drug effects	neoplasms/complications	0.03125	34162429
immune checkpoint inhibitors/adverse effects	steroids/therapeutic use	0.8019736842105263	33290513
immune checkpoint inhibitors/adverse effects	inflammation	0.5520833333333333	32888202
immune checkpoint inhibitors/adverse effects	prednisone/therapeutic use	0.5520833333333333	34956219
adrenal gland diseases/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
immune checkpoint inhibitors/adverse effects	BTLA	0.5520833333333333	36159840
colitis/diagnosis	gastrointestinal tract/metabolism	0.020833333333333336	32298485
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	36159840
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	32389505
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	34992611
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	32702598
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	33555016
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	33173388
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	34158318
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	32960847
immune checkpoint inhibitors/adverse effects	CD274	0.45373514530306297	35432346
immune checkpoint inhibitors/adverse effects	CD28	0.5520833333333333	36159840
immune checkpoint inhibitors/adverse effects	CD4	0.30219298245614035	33555016
immune checkpoint inhibitors/adverse effects	CD4	0.30219298245614035	34338882
inflammation/drug therapy	colitis/drug therapy	0.0618421052631579	32603654
immune checkpoint inhibitors/adverse effects	CD68	0.30219298245614035	33555016
immune checkpoint inhibitors/adverse effects	CD68	0.30219298245614035	34338882
inflammation/drug therapy	diarrhea/chemically induced	0.2894736842105262	36113896
immune checkpoint inhibitors/adverse effects	CD8A	0.5990249274001151	33555016
immune checkpoint inhibitors/adverse effects	CD8A	0.5990249274001151	34338882
immune checkpoint inhibitors/adverse effects	CD8A	0.5990249274001151	34147519
immune checkpoint inhibitors/adverse effects	CSF2	0.5520833333333333	36159840
colitis/diagnosis	b7-h1 antigen/metabolism	0.020833333333333336	32298485
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	34992611
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	32702598
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	32603654
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	33555016
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	32567084
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	35432346
immune checkpoint inhibitors/adverse effects	CTLA4	0.5340455904704406	34147519
immune checkpoint inhibitors/adverse effects	HAVCR2	0.5520833333333333	36159840
lymphocytes tumor-infiltrating/metabolism	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
inflammation/drug therapy	colitis/chemically induced	0.9287280701754386	36113896
immune checkpoint inhibitors/adverse effects	IL15	0.5520833333333333	36159840
myasthenia gravis/diagnosis	skin neoplasms/immunology	0.010416666666666668	34956219
immune checkpoint inhibitors/adverse effects	IL17C	0.5520833333333333	36159840
lymphocytes tumor-infiltrating/metabolism	b7-h1 antigen/genetics	0.010416666666666668	33462141
immune checkpoint inhibitors/adverse effects	IL21	0.5520833333333333	36159840
immune checkpoint inhibitors/adverse effects	IL22	0.8019736842105263	36159840
immune checkpoint inhibitors/adverse effects	IL4	0.5520833333333333	36159840
colitis/diagnosis	CD274	0.2894736842105262	32298485
immune checkpoint inhibitors/adverse effects	IL6	0.8019736842105263	36159840
inflammation/drug therapy	receptors antigen t-cell/genetics	0.020833333333333336	32603654
immune checkpoint inhibitors/adverse effects	LIF	0.5520833333333333	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	34992611
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	32702598
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	32603654
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	33555016
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	33906378
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	33173388
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	32567084
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	34158318
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	32960847
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	35432346
immune checkpoint inhibitors/adverse effects	PDCD1	0.8590874826357457	34147519
immune checkpoint inhibitors/adverse effects	SNCA	0.9136268197088466	33476895
inflammation/drug therapy	t-lymphocytes regulatory/cytology	0.020833333333333336	32603654
metabolome/drug effects	colitis/etiology	0.020833333333333332	34162429
myasthenia gravis/diagnosis	colitis/chemically induced	0.7291666666666666	34956219
colitis/diagnosis	PDCD1	0.45504385964912286	32298485
exanthema/chemically induced	bevacizumab/administration & dosage	0.010416666666666668	32130969
inflammation/drug therapy	chemokines/metabolism	0.020833333333333336	32603654
myasthenia gravis/diagnosis	melanoma/immunology	0.010416666666666668	34956219
inflammation/drug therapy	multigene family	0.020833333333333336	32603654
exanthema/chemically induced	pneumonia/chemically induced	0.03125	32130969
lymphocytes tumor-infiltrating/metabolism	APC	0.020833333333333332	33462141
metabolome/drug effects	antineoplastic agents immunological/adverse effects	0.07291666666666667	34162429
lymphocytes tumor-infiltrating/metabolism	CD274	0.15624999999999997	33462141
exanthema/chemically induced	fatigue/chemically induced	0.010416666666666668	32130969
inflammation/drug therapy	beclomethasone/adverse effects	0.020833333333333336	36113896
lymphocytes tumor-infiltrating/metabolism	CD8A	0.05208333333333334	33462141
metabolome/drug effects	anti-bacterial agents/pharmacology	0.010416666666666668	34162429
myasthenia gravis/diagnosis	immunocompromised host	0.010416666666666668	34956219
exanthema/chemically induced	pruritus/chemically induced	0.010416666666666668	32130969
lymphocytes tumor-infiltrating/metabolism	IL17A	0.020833333333333332	33462141
lymphocytes tumor-infiltrating/metabolism	MIR15B	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	NRF1	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	PDCD1	0.26041666666666663	33462141
inflammation/drug therapy	CTLA4	0.23552631578947367	32603654
exanthema/chemically induced	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
immunosuppressive agents/therapeutic use	skin neoplasms/immunology	0.010416666666666668	34956219
exanthema/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
inflammation/drug therapy	PDCD1	0.45504385964912286	32603654
antibodies monoclonal humanized/adverse effects	immune checkpoint inhibitors/adverse effects	0.5520833333333333	34956219
immunosuppressive agents/therapeutic use	colitis/chemically induced	0.7291666666666666	34956219
myasthenia gravis/diagnosis	prednisone/therapeutic use	0.010416666666666668	34956219
exanthema/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
glucocorticoids	diarrhea/chemically induced	0.15624999999999997	36096534
antibodies monoclonal humanized/adverse effects	myasthenia gravis/diagnosis	0.010416666666666668	34956219
colon/diagnostic imaging	drug resistance/immunology	0.010416666666666668	32414860
exanthema/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
antibodies monoclonal humanized/adverse effects	immunosuppressive agents/therapeutic use	0.010416666666666668	34956219
glucocorticoids	colitis/chemically induced	0.7291666666666666	36096534
colon/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32414860
exanthema/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
immunosuppressive agents/therapeutic use	melanoma/immunology	0.010416666666666668	34956219
exanthema/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
immunosuppressive agents/therapeutic use	immunocompromised host	0.010416666666666668	34956219
exanthema/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
antibodies monoclonal humanized/adverse effects	skin neoplasms/immunology	0.010416666666666668	34956219
colon/diagnostic imaging	skin neoplasms/drug therapy	0.020833333333333332	32414860
colon/diagnostic imaging	infliximab/adverse effects	0.041666666666666664	32414860
exanthema/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
exanthema/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
antibodies monoclonal humanized/adverse effects	colitis/chemically induced	0.7291666666666666	34956219
antibodies monoclonal humanized/adverse effects	melanoma/immunology	0.010416666666666668	34956219
exanthema/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
immunosuppressive agents/therapeutic use	prednisone/therapeutic use	0.010416666666666668	34956219
glucocorticoids	CHI3L1	0.010416666666666668	36096534
glucocorticoids	CXCL8	0.010416666666666668	36096534
antibodies monoclonal humanized/adverse effects	immunocompromised host	0.010416666666666668	34956219
colon/diagnostic imaging	colitis/chemically induced	0.7291666666666666	32414860
glucocorticoids	IL17A	0.020833333333333332	36096534
ctla-4 antigen/immunology	colitis/drug therapy	0.03125	32603654
colon/diagnostic imaging	glucocorticoids/pharmacology	0.010416666666666668	32414860
glucocorticoids	IL6	0.020833333333333332	36096534
colon/diagnostic imaging	melanoma/drug therapy	0.05208333333333334	32414860
ctla-4 antigen/immunology	receptors antigen t-cell/genetics	0.010416666666666668	32603654
interferon-gamma/metabolism	immunologic memory/drug effects	0.010416666666666668	34147519
antibodies monoclonal humanized/adverse effects	prednisone/therapeutic use	0.010416666666666668	34956219
interferon-gamma/metabolism	colon/drug effects	0.03125	34147519
ctla-4 antigen/immunology	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
colon/diagnostic imaging	immunosuppressive agents/pharmacology	0.010416666666666668	32414860
macrophages/drug effects	colon/drug effects	0.03125	34338882
colon/diagnostic imaging	mucositis/chemically induced	0.010416666666666668	32414860
bevacizumab/administration & dosage	pneumonia/chemically induced	0.03125	32130969
bevacizumab/administration & dosage	fatigue/chemically induced	0.010416666666666668	32130969
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3021929824561404	33096100
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3021929824561404	34147519
ctla-4 antigen/immunology	chemokines/metabolism	0.010416666666666668	32603654
bevacizumab/administration & dosage	pruritus/chemically induced	0.010416666666666668	32130969
ctla-4 antigen/immunology	multigene family	0.010416666666666668	32603654
bevacizumab/administration & dosage	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
pyrimidines/therapeutic use	interferon-gamma/metabolism	0.020833333333333336	34147519
interferon-gamma/metabolism	piperidines/therapeutic use	0.020833333333333332	34147519
pyrimidines/therapeutic use	immunologic memory/drug effects	0.020833333333333336	34147519
bevacizumab/administration & dosage	axitinib/administration & dosage	0.010416666666666668	32130969
pyrimidines/therapeutic use	colon/drug effects	0.0618421052631579	34147519
macrophages/drug effects	crohn disease/immunology	0.010416666666666668	34338882
interferon-gamma/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34147519
pyrimidines/therapeutic use	protein kinase inhibitors/therapeutic use	0.020833333333333336	33096100
interferon-gamma/metabolism	ctla-4 antigen/antagonists & inhibitors	0.03125	34147519
pyrimidines/therapeutic use	neoplasms/drug therapy	0.23552631578947367	33096100
interferon-gamma/metabolism	cd8-positive t-lymphocytes/drug effects	0.020833333333333332	34147519
ctla-4 antigen/immunology	CTLA4	0.125	32603654
interferon-gamma/metabolism	phenotype	0.020833333333333332	34147519
bevacizumab/administration & dosage	colitis/chemically induced	0.7291666666666666	32130969
pyrimidines/therapeutic use	ipilimumab/adverse effects	0.17960526315789477	33096100
bevacizumab/administration & dosage	hypophysitis/chemically induced	0.010416666666666668	32130969
interferon-gamma/metabolism	CD8A	0.05208333333333334	34147519
interferon-gamma/metabolism	CTLA4	0.125	34147519
bevacizumab/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
pyrimidines/therapeutic use	colitis/chemically induced	0.9287280701754386	33096100
ctla-4 antigen/immunology	PDCD1	0.26041666666666663	32603654
drug resistance/immunology	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32414860
interferon-gamma/metabolism	PDCD1	0.26041666666666663	34147519
bevacizumab/administration & dosage	myocarditis/chemically induced	0.010416666666666668	32130969
bevacizumab/administration & dosage	hepatitis autoimmune/etiology	0.010416666666666668	32130969
pyrimidines/therapeutic use	piperidines/therapeutic use	0.0002192982456140351	33096100
pyrimidines/therapeutic use	piperidines/therapeutic use	0.0002192982456140351	34147519
pneumonia/chemically induced	fatigue/chemically induced	0.03125	32130969
macrophages/drug effects	graft vs host disease/immunology	0.010416666666666668	34338882
pneumonia/chemically induced	immune checkpoint inhibitors	0.6797312430011198	35124713
bevacizumab/administration & dosage	myasthenia gravis/chemically induced	0.010416666666666668	32130969
pyrimidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34147519
drug resistance/immunology	skin neoplasms/drug therapy	0.020833333333333332	32414860
macrophages/drug effects	cd8-positive t-lymphocytes/drug effects	0.020833333333333332	34338882
mesalamine/pharmacology	colon/drug effects	0.03125	33506015
bevacizumab/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
drug resistance/immunology	infliximab/adverse effects	0.041666666666666664	32414860
pneumonia/chemically induced	pruritus/chemically induced	0.03125	32130969
macrophages/drug effects	phenotype	0.020833333333333332	34338882
pneumonia/chemically induced	antibodies monoclonal humanized/administration & dosage	0.03125	32540858
pyrimidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.0618421052631579	34147519
pneumonia/chemically induced	adrenal insufficiency/chemically induced	0.03125	32130969
pyrimidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.041447368421052636	34147519
pneumonia/chemically induced	carcinoma non-small-cell lung/drug therapy	0.06184210526315789	35124713
macrophages/drug effects	CD4	0.020833333333333332	34338882
macrophages/drug effects	CD68	0.020833333333333332	34338882
macrophages/drug effects	CD8A	0.05208333333333334	34338882
pyrimidines/therapeutic use	phenotype	0.041447368421052636	34147519
mesalamine/pharmacology	colitis/chemically induced	0.7291666666666666	33506015
pneumonia/chemically induced	axitinib/administration & dosage	0.03125	32130969
bevacizumab/administration & dosage	ipilimumab/therapeutic use	0.03125	32130969
pyrimidines/therapeutic use	CD8A	0.10197368421052633	34147519
pyrimidines/therapeutic use	CTLA4	0.23552631578947367	34147519
drug resistance/immunology	colitis/chemically induced	0.7291666666666666	32414860
pneumonia/chemically induced	immune checkpoint inhibitors/administration & dosage	0.12108062709966405	32540858
mesalamine/pharmacology	immune checkpoint inhibitors/pharmacology	0.041666666666666664	33506015
drug resistance/immunology	glucocorticoids/pharmacology	0.010416666666666668	32414860
pneumonia/chemically induced	colitis/chemically induced	0.3831187010078388	35124713
pneumonia/chemically induced	colitis/chemically induced	0.3831187010078388	32540858
pneumonia/chemically induced	colitis/chemically induced	0.3831187010078388	32130969
pyrimidines/therapeutic use	PDCD1	0.45504385964912286	34147519
mesalamine/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33506015
pneumonia/chemically induced	hypophysitis/chemically induced	0.03125	32130969
mesalamine/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010416666666666668	33506015
pneumonia/chemically induced	angiogenesis inhibitors/therapeutic use	0.03125	32130969
myocarditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5520833333333333	33375984
drug resistance/immunology	melanoma/drug therapy	0.05208333333333334	32414860
pneumonia/chemically induced	myocarditis/chemically induced	0.03125	32130969
myocarditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010416666666666668	33375984
myocarditis/diagnostic imaging	neoplasms/diagnostic imaging	0.020833333333333332	33375984
pneumonia/chemically induced	hepatitis autoimmune/etiology	0.03125	32130969
drug resistance/immunology	immunosuppressive agents/pharmacology	0.010416666666666668	32414860
mesalamine/pharmacology	ACAD8	0.020833333333333332	33506015
pneumonia/chemically induced	dose-response relationship drug	0.09178331466965287	32540858
pneumonia/chemically induced	myasthenia gravis/chemically induced	0.03125	32130969
programmed cell death 1 receptor/metabolism	colitis/diagnosis	0.020833333333333332	32298485
pneumonia/chemically induced	immune checkpoint inhibitors/therapeutic use	0.06184210526315789	32130969
myocarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010416666666666668	33375984
drug resistance/immunology	mucositis/chemically induced	0.010416666666666668	32414860
pneumonia/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.23197088465845458	32540858
mesalamine/pharmacology	PDCD1	0.26041666666666663	33506015
myocarditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010416666666666668	33375984
immunologic memory/drug effects	colon/drug effects	0.03125	34147519
myocarditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
myocarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
pneumonia/chemically induced	ipilimumab/therapeutic use	0.001959686450167973	35124713
pneumonia/chemically induced	ipilimumab/therapeutic use	0.001959686450167973	32130969
pneumonia/chemically induced	drugs investigational/administration & dosage	0.03125	32540858
myocarditis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
colitis collagenous/drug therapy	immune checkpoint inhibitors/pharmacology	0.041666666666666664	32404733
pneumonia/chemically induced	CD274	0.40285554311310195	32540858
colitis collagenous/drug therapy	melanoma/complications	0.03125	32404733
pneumonia/chemically induced	PDCD1	0.5999790033594625	32540858
immunologic memory/drug effects	piperidines/therapeutic use	0.020833333333333332	34147519
myocarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
immunologic memory/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34147519
colitis ulcerative/drug therapy	immune checkpoint inhibitors/adverse effects	0.9628502450360631	33567198
programmed cell death 1 receptor/metabolism	immune checkpoint inhibitors/pharmacology	0.041666666666666664	32298485
immunologic memory/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03125	34147519
programmed cell death 1 receptor/metabolism	inflammatory bowel diseases	0.020833333333333332	32298485
immunologic memory/drug effects	cd8-positive t-lymphocytes/drug effects	0.020833333333333332	34147519
immunologic memory/drug effects	phenotype	0.020833333333333332	34147519
colitis ulcerative/drug therapy	immune checkpoint inhibitors	0.7830437452588231	33058056
immunologic memory/drug effects	CD8A	0.05208333333333334	34147519
programmed cell death 1 receptor/metabolism	gastrointestinal tract/metabolism	0.010416666666666668	32298485
immunologic memory/drug effects	CTLA4	0.125	34147519
colitis collagenous/drug therapy	PDCD1	0.26041666666666663	32404733
glycoproteins/metabolism	b7-h1 antigen/antagonists & inhibitors	0.03125	32389505
programmed cell death 1 receptor/metabolism	b7-h1 antigen/metabolism	0.010416666666666668	32298485
immunologic memory/drug effects	PDCD1	0.26041666666666663	34147519
programmed cell death 1 receptor/metabolism	CD274	0.15624999999999997	32298485
colitis ulcerative/drug therapy	recurrence	0.12108062709966406	36591847
skin neoplasms/complications	colitis collagenous/drug therapy	0.010416666666666668	32404733
neoplasm recurrence local/drug therapy	immune checkpoint inhibitors	0.3125	35801666
glycoproteins/metabolism	colitis/chemically induced	0.7291666666666666	32389505
programmed cell death 1 receptor/metabolism	PDCD1	0.26041666666666663	32298485
pruritus/chemically induced	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
colitis ulcerative/drug therapy	interleukin-23/antagonists & inhibitors	0.041666666666666664	33567198
pruritus/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
glycoproteins/metabolism	biomarkers/metabolism	0.010416666666666668	32389505
pruritus/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
arthritis/chemically induced	immune checkpoint inhibitors	0.3125	36096534
pruritus/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
arthritis/chemically induced	glucocorticoids	0.010416666666666668	36096534
colitis ulcerative/drug therapy	feces/chemistry	0.003891377379619262	21694533
colitis ulcerative/drug therapy	feces/chemistry	0.003891377379619262	36591847
pruritus/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
colitis ulcerative/drug therapy	crohn disease/drug therapy	0.041666666666666664	33058056
pruritus/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
neoplasm recurrence local/drug therapy	colitis/chemically induced	0.7291666666666666	35801666
colitis ulcerative/drug therapy	dose-response relationship drug	0.12108062709966406	21694533
glycoproteins/metabolism	adenocarcinoma of lung/drug therapy	0.010416666666666668	32389505
colitis ulcerative/drug therapy	leukocyte l1 antigen complex/analysis	0.003891377379619262	21694533
colitis ulcerative/drug therapy	leukocyte l1 antigen complex/analysis	0.003891377379619262	36591847
arthritis/chemically induced	diarrhea/chemically induced	0.15624999999999997	36096534
pruritus/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
neoplasm recurrence local/drug therapy	endometrial neoplasms/drug therapy	0.010416666666666668	35801666
pruritus/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
pruritus/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
arthritis/chemically induced	colitis/chemically induced	0.7291666666666666	36096534
neoplasm recurrence local/drug therapy	antibodies monoclonal humanized	0.010416666666666668	35801666
skin neoplasms/complications	immune checkpoint inhibitors/pharmacology	0.041666666666666664	32404733
pruritus/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
colitis ulcerative/drug therapy	interleukin-12/antagonists & inhibitors	0.041666666666666664	33567198
colitis ulcerative/drug therapy	biomarkers/analysis	0.12108062709966406	36591847
glycoproteins/metabolism	CD274	0.15624999999999997	32389505
skin neoplasms/complications	melanoma/complications	0.03125	32404733
pancreatitis/diagnostic imaging	neoplasms/diagnostic imaging	0.020833333333333332	33375984
colitis ulcerative/drug therapy	diarrhea/etiology	0.041666666666666664	21694533
colitis ulcerative/drug therapy	gastrointestinal hemorrhage/etiology	0.041666666666666664	21694533
colitis ulcerative/drug therapy	prednisolone/administration & dosage	0.041666666666666664	21694533
colitis ulcerative/drug therapy	glucocorticoids/administration & dosage	0.041666666666666664	21694533
colitis ulcerative/drug therapy	diarrhea/diagnosis	0.041666666666666664	36591847
colitis ulcerative/drug therapy	abdominal pain/etiology	0.041666666666666664	21694533
colitis ulcerative/drug therapy	colitis microscopic/diagnosis	0.041666666666666664	36591847
cd8-positive t-lymphocytes/cytology	inflammation/drug therapy	0.020833333333333332	32603654
cd8-positive t-lymphocytes/cytology	immune checkpoint inhibitors/adverse effects	0.5520833333333333	32603654
antibodies monoclonal humanized/administration & dosage	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	32540858
cd8-positive t-lymphocytes/cytology	myeloid cells/cytology	0.010416666666666668	32603654
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/immunology	0.010416666666666668	32603654
arthritis/chemically induced	CHI3L1	0.010416666666666668	36096534
pancreatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010416666666666668	33375984
antibodies monoclonal humanized/administration & dosage	colitis/chemically induced	0.7291666666666666	32540858
arthritis/chemically induced	CXCL8	0.010416666666666668	36096534
neoplasm recurrence local/drug therapy	PDCD1	0.26041666666666663	35801666
pancreatitis/diagnostic imaging	hepatitis/diagnostic imaging	0.010416666666666668	33375984
arthritis/chemically induced	IL17A	0.020833333333333332	36096534
arthritis/chemically induced	IL6	0.020833333333333332	36096534
skin neoplasms/complications	PDCD1	0.26041666666666663	32404733
cd8-positive t-lymphocytes/cytology	colitis/drug therapy	0.03125	32603654
pancreatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
pancreatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
immune checkpoint inhibitors	glucocorticoids	0.31250000000000006	36096534
antibodies monoclonal humanized/administration & dosage	dose-response relationship drug	0.03125	32540858
immune checkpoint inhibitors	skin neoplasms/drug therapy	0.5296052631578948	32641348
immune checkpoint inhibitors	infliximab/adverse effects	0.36979373622800993	32162824
immune checkpoint inhibitors	infliximab/adverse effects	0.36979373622800993	32584703
immune checkpoint inhibitors	lung neoplasms/drug therapy	0.5296052631578948	34716545
antibodies monoclonal humanized/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32540858
immune checkpoint inhibitors	diarrhea/therapy	0.31250000000000006	32780984
myeloid cells/cytology	ctla-4 antigen/immunology	0.010416666666666668	32603654
immune checkpoint inhibitors	tumor necrosis factor inhibitors	0.31250000000000006	32641348
cd8-positive t-lymphocytes/cytology	receptors antigen t-cell/genetics	0.010416666666666668	32603654
immune checkpoint inhibitors	colitis	0.08891287071487916	33314269
immune checkpoint inhibitors	colitis	0.08891287071487916	35842365
immune checkpoint inhibitors	colitis	0.08891287071487916	32780983
pancreatitis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
immune checkpoint inhibitors/adverse effects	myeloid cells/cytology	0.5520833333333333	32603654
immune checkpoint inhibitors/adverse effects	colitis ulcerative/physiopathology	0.5520833333333333	34821404
immune checkpoint inhibitors/adverse effects	myasthenia gravis/diagnosis	0.5520833333333333	34956219
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/immunology	0.5520833333333333	32603654
immune checkpoint inhibitors	carcinoma non-small-cell lung/drug therapy	0.5296052631578948	35124713
immune checkpoint inhibitors/adverse effects	glycoproteins/metabolism	0.5520833333333333	32389505
immune checkpoint inhibitors/adverse effects	pancreatitis/diagnostic imaging	0.5520833333333333	33375984
cd8-positive t-lymphocytes/cytology	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.30219298245614035	33375984
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.30219298245614035	31754740
antibodies monoclonal humanized/administration & dosage	drugs investigational/administration & dosage	0.010416666666666668	32540858
immune checkpoint inhibitors/adverse effects	colitis/diagnosis	0.8019736842105263	32028372
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/therapeutic use	0.5520833333333333	34956219
immune checkpoint inhibitors	inflammatory bowel diseases/drug therapy	0.6797312430011198	33314269
immune checkpoint inhibitors/adverse effects	macrophages/drug effects	0.5520833333333333	34338882
immune checkpoint inhibitors/adverse effects	mycophenolic acid	0.5520833333333333	36504035
antibodies monoclonal humanized/administration & dosage	CD274	0.15624999999999997	32540858
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.09539473684210527	34170536
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.09539473684210527	32401685
immune checkpoint inhibitors	colitis/drug therapy	0.6797312430011198	32780984
immune checkpoint inhibitors/adverse effects	interferon-gamma/metabolism	0.5520833333333333	34147519
immune checkpoint inhibitors	recurrence	0.6797312430011198	35842365
immune checkpoint inhibitors/adverse effects	immunologic memory/drug effects	0.5520833333333333	34147519
immune checkpoint inhibitors	diarrhea/chemically induced	0.5343954056880231	32641348
immune checkpoint inhibitors	diarrhea/chemically induced	0.5343954056880231	36113896
immune checkpoint inhibitors	diarrhea/chemically induced	0.5343954056880231	35917654
immune checkpoint inhibitors	diarrhea/chemically induced	0.5343954056880231	36096534
immune checkpoint inhibitors	diarrhea/chemically induced	0.5343954056880231	32584703
immune checkpoint inhibitors	immunologic factors	0.09539473684210527	33566405
immune checkpoint inhibitors	immunologic factors	0.09539473684210527	33566423
immune checkpoint inhibitors/adverse effects	skin neoplasms/drug therapy	0.8019736842105263	32414860
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.5786674132138858	34338882
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.5786674132138858	34147519
immune checkpoint inhibitors	ipilimumab/adverse effects	0.5772646283775837	35191192
immune checkpoint inhibitors	ipilimumab/adverse effects	0.5772646283775837	32934876
immune checkpoint inhibitors	ipilimumab/adverse effects	0.5772646283775837	35917654
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7659565437271971	32414860
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7659565437271971	33454238
immune checkpoint inhibitors/adverse effects	lung neoplasms/drug therapy	0.8019736842105263	33173388
antibodies monoclonal humanized/administration & dosage	PDCD1	0.26041666666666663	32540858
immune checkpoint inhibitors/adverse effects	disease progression	0.5520833333333333	36377339
immune checkpoint inhibitors/adverse effects	colitis	0.9628502450360631	35432346
immune checkpoint inhibitors	neoplasms/therapy	0.31250000000000006	32780984
immune checkpoint inhibitors/adverse effects	gastritis/chemically induced	0.5520833333333333	32621258
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.01763717805151176	33506015
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.01763717805151176	34147519
myeloid cells/cytology	colitis/drug therapy	0.03125	32603654
immune checkpoint inhibitors/adverse effects	protein kinase inhibitors/therapeutic use	0.5520833333333333	33096100
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	34081152
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	34716545
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	32162824
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	36096534
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35307927
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35191192
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	34106395
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	34515105
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35977003
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35296560
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	34256056
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35801666
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	32641348
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	33566405
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35917654
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	32934876
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	36113896
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	35124713
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	31864555
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	33746162
immune checkpoint inhibitors	colitis/chemically induced	0.7543638723819438	32584703
immune checkpoint inhibitors/adverse effects	colitis/epidemiology	0.5520833333333333	32960847
immune checkpoint inhibitors/adverse effects	sarcoidosis/diagnostic imaging	0.5520833333333333	33375984
immune checkpoint inhibitors/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.5520833333333333	33476895
colon/drug effects	trinitrobenzenesulfonic acid/adverse effects	0.03125	33506015
immune checkpoint inhibitors/adverse effects	tongue neoplasms/drug therapy	0.5520833333333333	33476895
colon/drug effects	ctla-4 antigen/antagonists & inhibitors	0.09178331466965287	34147519
immune checkpoint inhibitors/adverse effects	carcinoma non-small-cell lung/drug therapy	0.8019736842105263	34992611
skin neoplasms/drug therapy	infliximab/adverse effects	0.08201754385964914	32414860
immune checkpoint inhibitors	endometrial neoplasms/drug therapy	0.31250000000000006	35801666
immune checkpoint inhibitors/adverse effects	gentian violet	0.5520833333333333	32888202
immune checkpoint inhibitors/adverse effects	hepatitis/diagnostic imaging	0.5520833333333333	33375984
immune checkpoint inhibitors	dermatitis	0.31250000000000006	35977003
pancreatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
immune checkpoint inhibitors/adverse effects	chemical and drug induced liver injury/diagnosis	0.5520833333333333	33080231
skin neoplasms/drug therapy	tumor necrosis factor inhibitors	0.020833333333333336	32641348
colon/drug effects	graft vs host disease/immunology	0.03125	34338882
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.16395576707726767	32389505
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.16395576707726767	32702598
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.16395576707726767	32960847
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.5786674132138858	33555016
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.5786674132138858	35277350
immune checkpoint inhibitors/adverse effects	antibodies monoclonal humanized/therapeutic use	0.5520833333333333	33454238
immune checkpoint inhibitors	antibodies monoclonal humanized	0.31250000000000006	35801666
immune checkpoint inhibitors/adverse effects	skin neoplasms/immunology	0.5520833333333333	34956219
myeloid cells/cytology	receptors antigen t-cell/genetics	0.010416666666666668	32603654
immune checkpoint inhibitors/adverse effects	steroids/adverse effects	0.5520833333333333	33454238
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0006578947368421052	34338882
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0006578947368421052	34147519
immune checkpoint inhibitors/adverse effects	lymphocytes/drug effects	0.5520833333333333	32567084
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	33741313
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	33096100
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	31609734
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	33080231
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	33436487
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	33459466
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	34777387
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	34107499
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	34380976
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	32185493
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00567405534370603	36377339
colon/drug effects	phenotype	0.0006578947368421052	34338882
colon/drug effects	phenotype	0.0006578947368421052	34147519
immune checkpoint inhibitors/adverse effects	feces	0.5520833333333333	33290513
immune checkpoint inhibitors	melanoma/drug therapy	0.5000573260312011	32162824
immune checkpoint inhibitors	melanoma/drug therapy	0.5000573260312011	32641348
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.5786674132138858	32603654
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.5786674132138858	33436487
immune checkpoint inhibitors	crohn disease/drug therapy	0.31250000000000006	33058056
immune checkpoint inhibitors/adverse effects	crohn disease/physiopathology	0.5520833333333333	34821404
skin neoplasms/drug therapy	diarrhea/chemically induced	0.2894736842105262	32641348
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	31609734
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	33436487
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	34107499
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	33173388
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	34158318
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	34380976
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	33290513
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	31595568
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.45373514530306297	36377339
myeloid cells/cytology	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
colon/drug effects	ACAD8	0.06184210526315789	33506015
immune checkpoint inhibitors/adverse effects	proton pump inhibitors/adverse effects	0.5520833333333333	35277350
immune checkpoint inhibitors	drug-related side effects and adverse reactions/diagnosis	0.31250000000000006	35191192
immune checkpoint inhibitors/adverse effects	pericarditis/diagnostic imaging	0.5520833333333333	33375984
immune checkpoint inhibitors	inflammatory bowel diseases	0.5296052631578948	35842365
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	34159488
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	33096100
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	33882697
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	34332139
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	31595568
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.35868679622574856	32931028
skin neoplasms/drug therapy	colitis/chemically induced	0.5296052631578946	32414860
skin neoplasms/drug therapy	colitis/chemically induced	0.5296052631578946	32641348
immune checkpoint inhibitors/adverse effects	encephalitis/diagnostic imaging	0.5520833333333333	33375984
colon/drug effects	CD4	0.06184210526315789	34338882
immune checkpoint inhibitors/adverse effects	dysbiosis/etiology	0.5520833333333333	34162429
skin neoplasms/drug therapy	glucocorticoids/pharmacology	0.020833333333333336	32414860
colon/drug effects	CD68	0.06184210526315789	34338882
immune checkpoint inhibitors/adverse effects	clostridium infections/chemically induced	0.5520833333333333	34107499
colon/drug effects	CD8A	0.006438969764837627	34338882
colon/drug effects	CD8A	0.006438969764837627	34147519
immune checkpoint inhibitors/adverse effects	anti-bacterial agents	0.5520833333333333	36043345
immune checkpoint inhibitors	drug-related side effects and adverse reactions	0.5296052631578948	32162824
immune checkpoint inhibitors/adverse effects	interleukin-23/antagonists & inhibitors	0.5520833333333333	33567198
colon/drug effects	CTLA4	0.33311870100783875	34147519
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34159488
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33741313
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32389505
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34751747
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32422528
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32702598
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	31609734
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36389768
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33459466
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33268234
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33173388
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32888202
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32414860
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33290513
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32185493
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33454238
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33096100
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	35277350
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33080231
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34777387
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32567084
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34380976
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	31595568
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34956219
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32434876
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33555016
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33882697
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	33906378
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32621258
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36338892
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36043345
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	32931028
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36159840
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36504035
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34992611
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34332139
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34107499
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36189293
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	34158318
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	31754740
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.19576117100009974	36377339
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.16395576707726767	34162429
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.16395576707726767	34158318
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.16395576707726767	32960847
immune checkpoint inhibitors/adverse effects	abdominal pain/chemically induced	0.5520833333333333	36377339
skin neoplasms/drug therapy	melanoma/drug therapy	0.002192982456140351	32414860
skin neoplasms/drug therapy	melanoma/drug therapy	0.002192982456140351	32641348
immune checkpoint inhibitors/adverse effects	crohn disease/immunology	0.5520833333333333	34338882
immune checkpoint inhibitors/adverse effects	glucocorticoids/pharmacology	0.5520833333333333	32414860
immune checkpoint inhibitors/adverse effects	cytomegalovirus infections/diagnosis	0.5520833333333333	32434876
colon/drug effects	PDCD1	0.1651735722284434	33506015
colon/drug effects	PDCD1	0.1651735722284434	34147519
immune checkpoint inhibitors/adverse effects	paclitaxel/therapeutic use	0.5520833333333333	33476895
immune checkpoint inhibitors	lung neoplasms	0.31250000000000006	31864555
immune checkpoint inhibitors	cd8-positive t-lymphocytes	0.31250000000000006	34106395
myeloid cells/cytology	chemokines/metabolism	0.010416666666666668	32603654
immune checkpoint inhibitors/adverse effects	receptors antigen t-cell/genetics	0.5520833333333333	32603654
skin neoplasms/drug therapy	immunosuppressive agents/pharmacology	0.020833333333333336	32414860
immune checkpoint inhibitors/adverse effects	biomarkers/metabolism	0.5520833333333333	32389505
immune checkpoint inhibitors	beclomethasone/adverse effects	0.31250000000000006	36113896
immune checkpoint inhibitors/adverse effects	colitis/diagnostic imaging	0.5520833333333333	33375984
myeloid cells/cytology	multigene family	0.010416666666666668	32603654
immune checkpoint inhibitors	ipilimumab/therapeutic use	0.6797312430011198	35124713
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/adverse effects	0.5520833333333333	34107499
immune checkpoint inhibitors/adverse effects	oropharyngeal neoplasms/drug therapy	0.5520833333333333	33906378
skin neoplasms/drug therapy	mucositis/chemically induced	0.020833333333333336	32414860
immune checkpoint inhibitors/adverse effects	vitamin d/administration & dosage	0.5520833333333333	32567084
immune checkpoint inhibitors/adverse effects	melanoma/immunology	0.5520833333333333	34956219
immune checkpoint inhibitors	cytomegalovirus infections/complications	0.31250000000000006	35307927
immune checkpoint inhibitors/adverse effects	t-lymphocytes regulatory/cytology	0.5520833333333333	32603654
immune checkpoint inhibitors/adverse effects	intestinal mucosa/immunology	0.5520833333333333	33459466
immune checkpoint inhibitors	inflammatory bowel diseases/complications	0.5296052631578948	32401685
immune checkpoint inhibitors/adverse effects	disease susceptibility	0.5520833333333333	32028372
immune checkpoint inhibitors	rna	0.31250000000000006	35977003
immune checkpoint inhibitors/adverse effects	colitis ulcerative/chemically induced	0.5520833333333333	33476895
immune checkpoint inhibitors	steroids/therapeutic use	0.5296052631578948	31864555
immune checkpoint inhibitors/adverse effects	feces/chemistry	0.9136268197088466	33436487
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.5990249274001151	33882697
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.5990249274001151	36338892
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.5990249274001151	32414860
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.5786674132138858	36159840
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.5786674132138858	36377339
neoplasms/diagnostic imaging	sarcoidosis/diagnostic imaging	0.020833333333333336	33375984
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.30219298245614035	33096100
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.30219298245614035	34147519
infliximab/adverse effects	antibodies monoclonal humanized/therapeutic use	0.041666666666666664	33454238
immune checkpoint inhibitors/adverse effects	adrenal cortex hormones/pharmacology	0.5520833333333333	33268234
infliximab/adverse effects	steroids/adverse effects	0.041666666666666664	33454238
immune checkpoint inhibitors/adverse effects	immunocompromised host	0.5520833333333333	34956219
immune checkpoint inhibitors	CD274	0.9121964539561995	32934876
immune checkpoint inhibitors	CD274	0.9121964539561995	33314269
immune checkpoint inhibitors	CD274	0.9121964539561995	35917654
immune checkpoint inhibitors/adverse effects	colon/immunology	0.30219298245614035	33459466
immune checkpoint inhibitors/adverse effects	colon/immunology	0.30219298245614035	34777387
neoplasms/diagnostic imaging	hepatitis/diagnostic imaging	0.020833333333333336	33375984
immune checkpoint inhibitors/adverse effects	dose-response relationship drug	0.9136268197088466	33290513
immune checkpoint inhibitors/adverse effects	neutrophils/drug effects	0.5520833333333333	32567084
infliximab/adverse effects	diarrhea/chemically induced	0.49916916519163396	32584703
immune checkpoint inhibitors	CHI3L1	0.31250000000000006	36096534
myeloid cells/cytology	CTLA4	0.125	32603654
immune checkpoint inhibitors/adverse effects	antibodies monoclonal/adverse effects	0.5520833333333333	32567084
immune checkpoint inhibitors/adverse effects	colitis/etiology	0.8019736842105263	34162429
immune checkpoint inhibitors	CTLA4	0.3010664666878406	35977003
immune checkpoint inhibitors	CTLA4	0.3010664666878406	35917654
immune checkpoint inhibitors	CTLA4	0.3010664666878406	35191192
immune checkpoint inhibitors	CTLA4	0.3010664666878406	32934876
immune checkpoint inhibitors	CTLA4	0.3010664666878406	33314269
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/pharmacology	0.5520833333333333	32414860
immune checkpoint inhibitors	CXCL10	0.31250000000000006	35977003
immune checkpoint inhibitors	CXCL8	0.31250000000000006	36096534
immune checkpoint inhibitors/adverse effects	leukocyte l1 antigen complex/analysis	0.9136268197088466	33436487
immune checkpoint inhibitors	CXCL9	0.31250000000000006	35977003
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.480085778617042	34147519
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.480085778617042	32702598
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.480085778617042	32567084
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.480085778617042	32960847
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.480085778617042	33476895
skin neoplasms/drug therapy	SNCA	0.0618421052631579	32641348
immune checkpoint inhibitors/adverse effects	gastrointestinal neoplasms/drug therapy	0.5520833333333333	36159840
immune checkpoint inhibitors	IL17A	0.5296052631578948	36096534
infliximab/adverse effects	colitis/chemically induced	0.27601024696263654	32162824
infliximab/adverse effects	colitis/chemically induced	0.27601024696263654	32414860
infliximab/adverse effects	colitis/chemically induced	0.27601024696263654	33454238
infliximab/adverse effects	colitis/chemically induced	0.27601024696263654	32584703
skin neoplasms/drug therapy	TNF	0.0618421052631579	32641348
immune checkpoint inhibitors/adverse effects	ligands	0.5520833333333333	35432346
neoplasms/diagnostic imaging	pericarditis/diagnostic imaging	0.020833333333333336	33375984
immune checkpoint inhibitors/adverse effects	postoperative complications	0.5520833333333333	32028372
immune checkpoint inhibitors/adverse effects	melanoma/complications	0.9136268197088466	32567084
neoplasms/diagnostic imaging	encephalitis/diagnostic imaging	0.020833333333333336	33375984
immune checkpoint inhibitors	IL6	0.5296052631578948	36096534
infliximab/adverse effects	glucocorticoids/pharmacology	0.041666666666666664	32414860
myeloid cells/cytology	PDCD1	0.26041666666666663	32603654
immune checkpoint inhibitors/adverse effects	adenocarcinoma of lung/drug therapy	0.5520833333333333	32389505
immune checkpoint inhibitors	LTF	0.31250000000000006	32584703
immune checkpoint inhibitors/adverse effects	chemokines/metabolism	0.5520833333333333	32603654
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.16395576707726767	32567084
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.16395576707726767	32702598
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.16395576707726767	34147519
immune checkpoint inhibitors/adverse effects	t-lymphocyte subsets/immunology	0.5520833333333333	34777387
immune checkpoint inhibitors	PDCD1	0.8783285075875299	35801666
immune checkpoint inhibitors	PDCD1	0.8783285075875299	35977003
immune checkpoint inhibitors	PDCD1	0.8783285075875299	32401685
immune checkpoint inhibitors	PDCD1	0.8783285075875299	35917654
immune checkpoint inhibitors	PDCD1	0.8783285075875299	35191192
immune checkpoint inhibitors	PDCD1	0.8783285075875299	33314269
neoplasms/diagnostic imaging	colitis/chemically induced	0.9287280701754386	31754740
immune checkpoint inhibitors/adverse effects	mucositis/chemically induced	0.5520833333333333	32414860
immune checkpoint inhibitors	SNCA	0.22935330347144453	32934876
immune checkpoint inhibitors	SNCA	0.22935330347144453	32641348
immune checkpoint inhibitors/adverse effects	multigene family	0.5520833333333333	32603654
immune checkpoint inhibitors	TCIM	0.31250000000000006	35977003
immune checkpoint inhibitors/adverse effects	gastritis/complications	0.5520833333333333	36377339
immune checkpoint inhibitors	TNF	0.028415453527435616	32162824
immune checkpoint inhibitors	TNF	0.028415453527435616	35977003
immune checkpoint inhibitors	TNF	0.028415453527435616	32641348
immune checkpoint inhibitors/adverse effects	biological products/therapeutic use	0.5520833333333333	34380976
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.30219298245614035	36377339
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.30219298245614035	34821404
immune checkpoint inhibitors/adverse effects	graft vs host disease/immunology	0.5520833333333333	34338882
neoplasms/diagnostic imaging	colitis/diagnostic imaging	0.020833333333333336	33375984
infliximab/adverse effects	melanoma/drug therapy	0.012602499729075609	32162824
infliximab/adverse effects	melanoma/drug therapy	0.012602499729075609	32414860
neoplasms/diagnosis	pneumonia/chemically induced	0.03125	32540858
infliximab/adverse effects	immunosuppressive agents/pharmacology	0.041666666666666664	32414860
infliximab/adverse effects	drug-related side effects and adverse reactions	0.08201754385964913	32162824
colon/drug effects	colitis/chemically induced	0.9818029115341546	33506015
neoplasms/diagnosis	antibodies monoclonal humanized/administration & dosage	0.010416666666666668	32540858
colon/drug effects	crohn disease/immunology	0.03125	34338882
infliximab/adverse effects	mucositis/chemically induced	0.041666666666666664	32414860
colitis/epidemiology	b7-h1 antigen/antagonists & inhibitors	0.03125	32960847
colon/drug effects	immune checkpoint inhibitors/pharmacology	0.12108062709966405	33506015
colon/drug effects	piperidines/therapeutic use	0.06184210526315789	34147519
t-lymphocytes cytotoxic/immunology	IL17A	0.020833333333333332	33462141
colitis/epidemiology	neoplasms/complications	0.03125	32960847
t-lymphocytes cytotoxic/immunology	MIR15B	0.010416666666666668	33462141
infliximab/adverse effects	LTF	0.041666666666666664	32584703
neoplasms/diagnostic imaging	pneumonia/diagnostic imaging	0.020833333333333336	33375984
t-lymphocytes cytotoxic/immunology	NRF1	0.010416666666666668	33462141
mycophenolic acid	colitis/chemically induced	0.7291666666666666	36504035
neoplasms/diagnosis	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	32540858
t-lymphocytes cytotoxic/immunology	PDCD1	0.26041666666666663	33462141
infliximab/adverse effects	TNF	0.12108062709966406	32162824
neoplasms/diagnosis	colitis/chemically induced	0.7291666666666666	32540858
hepatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
hepatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
colitis/epidemiology	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32960847
lung neoplasms/drug therapy	diarrhea/chemically induced	0.2894736842105262	33173388
lung neoplasms/drug therapy	colitis/chemically induced	0.5296052631578946	34716545
lung neoplasms/drug therapy	colitis/chemically induced	0.5296052631578946	33173388
neoplasms/diagnosis	dose-response relationship drug	0.03125	32540858
hepatitis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
neoplasms/diagnosis	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32540858
fatigue/chemically induced	pruritus/chemically induced	0.010416666666666668	32130969
colitis/epidemiology	CD274	0.15624999999999997	32960847
neoplasms/diagnosis	drugs investigational/administration & dosage	0.010416666666666668	32540858
hepatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
fatigue/chemically induced	adrenal insufficiency/chemically induced	0.010416666666666668	32130969
fatigue/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
neoplasms/diagnosis	CD274	0.15624999999999997	32540858
lung neoplasms/drug therapy	CD274	0.2894736842105262	33173388
colitis/epidemiology	PDCD1	0.26041666666666663	32960847
lung neoplasms/drug therapy	PDCD1	0.45504385964912286	33173388
neoplasms/diagnosis	PDCD1	0.26041666666666663	32540858
fatigue/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
sarcoidosis/diagnostic imaging	hepatitis/diagnostic imaging	0.010416666666666668	33375984
gene expression regulation neoplastic	lymphocytes tumor-infiltrating/metabolism	0.010416666666666668	33462141
chemical and drug induced liver injury/diagnosis	neoplasms/drug therapy	0.125	33080231
fatigue/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
diarrhea/therapy	colitis/drug therapy	0.03125	32780984
chemical and drug induced liver injury/diagnosis	colitis/chemically induced	0.7291666666666666	33080231
sarcoidosis/diagnostic imaging	pericarditis/diagnostic imaging	0.010416666666666668	33375984
sarcoidosis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	0.010416666666666668	33462141
diarrhea/therapy	neoplasms/therapy	0.010416666666666668	32780984
gene expression regulation neoplastic	tumor microenvironment/drug effects	0.010416666666666668	33462141
fatigue/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
sarcoidosis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
fatigue/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
gene expression regulation neoplastic	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
gene expression regulation neoplastic	ht29 cells	0.010416666666666668	33462141
gene expression regulation neoplastic	colitis/chemically induced	0.7291666666666666	33462141
fatigue/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
colitis ulcerative/physiopathology	crohn disease/physiopathology	0.010416666666666668	34821404
gene expression regulation neoplastic	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
gene expression regulation neoplastic	b7-h1 antigen/genetics	0.010416666666666668	33462141
fatigue/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
fatigue/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
sarcoidosis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
fatigue/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
axitinib/administration & dosage	colitis/chemically induced	0.7291666666666666	32130969
axitinib/administration & dosage	hypophysitis/chemically induced	0.010416666666666668	32130969
axitinib/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
disease progression	neoplasms/drug therapy	0.125	36377339
axitinib/administration & dosage	myocarditis/chemically induced	0.010416666666666668	32130969
disease progression	diarrhea/chemically induced	0.15624999999999997	36377339
gene expression regulation neoplastic	APC	0.020833333333333332	33462141
colitis ulcerative/physiopathology	enterocolitis/chemically induced	0.020833333333333332	34821404
axitinib/administration & dosage	hepatitis autoimmune/etiology	0.010416666666666668	32130969
gene expression regulation neoplastic	CD274	0.15624999999999997	33462141
disease progression	colitis/chemically induced	0.7291666666666666	36377339
axitinib/administration & dosage	myasthenia gravis/chemically induced	0.010416666666666668	32130969
disease progression	abdominal pain/chemically induced	0.010416666666666668	36377339
gene expression regulation neoplastic	CD8A	0.05208333333333334	33462141
axitinib/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
gene expression regulation neoplastic	IL17A	0.020833333333333332	33462141
disease progression	antineoplastic agents immunological/therapeutic use	0.03125	36377339
squamous cell carcinoma of head and neck/drug therapy	tongue neoplasms/drug therapy	0.010416666666666668	33476895
gene expression regulation neoplastic	MIR15B	0.010416666666666668	33462141
axitinib/administration & dosage	ipilimumab/therapeutic use	0.03125	32130969
gene expression regulation neoplastic	NRF1	0.010416666666666668	33462141
gene expression regulation neoplastic	PDCD1	0.26041666666666663	33462141
disease progression	gastritis/complications	0.010416666666666668	36377339
disease progression	enterocolitis/chemically induced	0.020833333333333332	36377339
squamous cell carcinoma of head and neck/drug therapy	paclitaxel/therapeutic use	0.010416666666666668	33476895
lymphocytes tumor-infiltrating/metabolism	t-lymphocytes cytotoxic/immunology	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	tumor microenvironment/drug effects	0.010416666666666668	33462141
tumor microenvironment/drug effects	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
tumor microenvironment/drug effects	ht29 cells	0.010416666666666668	33462141
tumor microenvironment/drug effects	colitis/chemically induced	0.7291666666666666	33462141
squamous cell carcinoma of head and neck/drug therapy	colitis ulcerative/chemically induced	0.010416666666666668	33476895
lymphocytes/drug effects	vitamin d/administration & dosage	0.010416666666666668	32567084
tumor microenvironment/drug effects	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
tumor microenvironment/drug effects	b7-h1 antigen/genetics	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	ht29 cells	0.010416666666666668	33462141
lymphocytes tumor-infiltrating/metabolism	colitis/chemically induced	0.7291666666666666	33462141
squamous cell carcinoma of head and neck/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33476895
lymphocytes/drug effects	neutrophils/drug effects	0.010416666666666668	32567084
tumor necrosis factor inhibitors	diarrhea/chemically induced	0.15624999999999997	32641348
lymphocytes/drug effects	antibodies monoclonal/adverse effects	0.010416666666666668	32567084
lymphocytes/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32567084
pericarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010416666666666668	33375984
tumor necrosis factor inhibitors	colitis/chemically induced	0.7291666666666666	32641348
lymphocytes/drug effects	melanoma/complications	0.03125	32567084
lymphocytes/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03125	32567084
squamous cell carcinoma of head and neck/drug therapy	antineoplastic agents immunological/adverse effects	0.07291666666666667	33476895
pericarditis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
lymphocytes/drug effects	antineoplastic agents immunological/adverse effects	0.07291666666666667	32567084
tumor necrosis factor inhibitors	melanoma/drug therapy	0.05208333333333334	32641348
tumor microenvironment/drug effects	APC	0.020833333333333332	33462141
tumor microenvironment/drug effects	CD274	0.15624999999999997	33462141
tumor microenvironment/drug effects	CD8A	0.05208333333333334	33462141
tumor microenvironment/drug effects	IL17A	0.020833333333333332	33462141
lymphocytes/drug effects	CTLA4	0.125	32567084
squamous cell carcinoma of head and neck/drug therapy	SNCA	0.03125	33476895
tumor microenvironment/drug effects	MIR15B	0.010416666666666668	33462141
pericarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
tumor microenvironment/drug effects	NRF1	0.010416666666666668	33462141
tumor microenvironment/drug effects	PDCD1	0.26041666666666663	33462141
lymphocytes/drug effects	PDCD1	0.26041666666666663	32567084
colitis/diagnosis	disease susceptibility	0.020833333333333336	32028372
tumor necrosis factor inhibitors	SNCA	0.03125	32641348
colitis/diagnosis	immune checkpoint inhibitors/pharmacology	0.08201754385964914	32298485
tumor necrosis factor inhibitors	TNF	0.03125	32641348
colitis/diagnosis	inflammatory bowel diseases	0.041447368421052636	32298485
neoplasms/drug therapy	colitis/drug therapy	0.3331187010078388	33436487
neoplasms/drug therapy	diarrhea/chemically induced	0.019598267251879607	31609734
neoplasms/drug therapy	diarrhea/chemically induced	0.019598267251879607	33436487
neoplasms/drug therapy	diarrhea/chemically induced	0.019598267251879607	34107499
neoplasms/drug therapy	diarrhea/chemically induced	0.019598267251879607	34380976
neoplasms/drug therapy	diarrhea/chemically induced	0.019598267251879607	36377339
neoplasms/drug therapy	ipilimumab/adverse effects	0.7160628624711188	33096100
neoplasms/drug therapy	clostridium infections/chemically induced	0.12500000000000003	34107499
colitis	inflammatory bowel diseases/drug therapy	0.12108062709966406	33314269
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.8225783874580066	32389505
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.8225783874580066	32702598
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	33741313
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	33096100
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	31609734
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	33080231
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	35236743
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	33459466
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	34777387
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	34107499
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	34380976
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	32185493
neoplasms/drug therapy	colitis/chemically induced	0.1070948700828539	36377339
b7-h1 antigen/antagonists & inhibitors	neoplasms/complications	0.09178331466965287	32960847
neoplasms/drug therapy	abdominal pain/chemically induced	0.12500000000000003	36377339
tongue neoplasms/drug therapy	paclitaxel/therapeutic use	0.010416666666666668	33476895
colitis	recurrence	0.12108062709966406	35842365
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	34159488
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	33096100
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	33882697
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	34332139
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	31595568
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	32931028
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	35917654
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	35191192
ipilimumab/adverse effects	colitis/chemically induced	0.05015916554474881	32934876
b7-h1 antigen/antagonists & inhibitors	biomarkers/metabolism	0.03125	32389505
neoplasms/drug therapy	anti-bacterial agents/adverse effects	0.12500000000000003	34107499
tongue neoplasms/drug therapy	colitis ulcerative/chemically induced	0.010416666666666668	33476895
neoplasms/drug therapy	intestinal mucosa/immunology	0.12500000000000003	33459466
neoplasms/drug therapy	feces/chemistry	0.3331187010078388	33436487
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.01763717805151176	32702598
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.01763717805151176	32960847
neoplasms/drug therapy	antineoplastic agents immunological/therapeutic use	0.3331187010078388	36377339
neoplasms/drug therapy	immune checkpoint inhibitors/pharmacology	0.4191679008777951	35236743
b7-h1 antigen/antagonists & inhibitors	adenocarcinoma of lung/drug therapy	0.03125	32389505
ipilimumab/adverse effects	melanoma/drug therapy	0.39549410523488754	33882697
neoplasms/drug therapy	piperidines/therapeutic use	0.23552631578947367	33096100
b7-h1 antigen/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.09178331466965287	32702598
ipilimumab/adverse effects	piperidines/therapeutic use	0.17960526315789474	33096100
tongue neoplasms/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33476895
neoplasms/drug therapy	colon/immunology	0.014473684210526316	33459466
neoplasms/drug therapy	colon/immunology	0.014473684210526316	34777387
colitis	inflammatory bowel diseases	0.08201754385964913	35842365
ipilimumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.09375000000000001	35191192
b7-h1 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.20517917133258673	32702598
neoplasms/drug therapy	leukocyte l1 antigen complex/analysis	0.3331187010078388	33436487
colitis/chemically induced	phthalazines/administration & dosage	0.7291666666666666	33495297
colitis/chemically induced	neoplasms/complications	0.9818029115341546	34158318
colitis/chemically induced	abdominal pain/chemically induced	0.7291666666666666	36377339
colitis/chemically induced	hypophysitis/chemically induced	0.7291666666666666	32130969
colitis/chemically induced	glucocorticoids/pharmacology	0.7291666666666666	32414860
neoplasms/drug therapy	t-lymphocyte subsets/immunology	0.12500000000000003	34777387
colitis/chemically induced	dextran sulfate/adverse effects	0.7291666666666666	33495297
colitis	ligands	0.041666666666666664	35432346
colitis/chemically induced	cytomegalovirus infections/diagnosis	0.7291666666666666	32434876
b7-h1 antigen/antagonists & inhibitors	CD274	0.0031844904815229564	32389505
b7-h1 antigen/antagonists & inhibitors	CD274	0.0031844904815229564	32702598
b7-h1 antigen/antagonists & inhibitors	CD274	0.0031844904815229564	32960847
neoplasms/drug therapy	gastritis/complications	0.12500000000000003	36377339
colitis/chemically induced	endometrial neoplasms/drug therapy	0.7291666666666666	35801666
tongue neoplasms/drug therapy	antineoplastic agents immunological/adverse effects	0.07291666666666667	33476895
neoplasms/drug therapy	biological products/therapeutic use	0.12500000000000003	34380976
colitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.7291666666666666	32130969
b7-h1 antigen/antagonists & inhibitors	CTLA4	0.33311870100783875	32702598
neoplasms/drug therapy	enterocolitis/chemically induced	0.23552631578947367	36377339
colitis/chemically induced	biomarkers/metabolism	0.7291666666666666	32389505
colitis/chemically induced	dermatitis	0.7291666666666666	35977003
colitis/chemically induced	colorectal neoplasms/drug therapy	0.7291666666666666	33462141
colitis/chemically induced	anti-bacterial agents/adverse effects	0.7291666666666666	34107499
neoplasms/drug therapy	hepatitis/diagnosis	0.12500000000000003	32185493
colitis/chemically induced	oropharyngeal neoplasms/drug therapy	0.7291666666666666	33906378
colitis/chemically induced	vitamin d/administration & dosage	0.7291666666666666	32567084
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.1651735722284434	32702598
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.1651735722284434	32960847
colitis/chemically induced	carcinoma non-small-cell lung/complications	0.7291666666666666	32418993
colitis/chemically induced	melanoma/immunology	0.7291666666666666	34956219
colitis/chemically induced	b7-h1 antigen/genetics	0.7291666666666666	33462141
neoplasms/drug therapy	biomarkers/analysis	0.3331187010078388	33436487
colitis/chemically induced	myocarditis/chemically induced	0.7291666666666666	32130969
colitis/chemically induced	antibodies monoclonal humanized	0.7291666666666666	35801666
neoplasms/drug therapy	butyrates/metabolism	0.12500000000000003	33741313
colitis/chemically induced	colonic neoplasms/drug therapy	0.7291666666666666	33495297
colitis/chemically induced	intestinal mucosa/immunology	0.7291666666666666	33459466
colitis/chemically induced	melanoma/drug therapy	0.1980073510818914	32641348
colitis/chemically induced	melanoma/drug therapy	0.1980073510818914	32162824
colitis/chemically induced	melanoma/drug therapy	0.1980073510818914	33882697
colitis/chemically induced	melanoma/drug therapy	0.1980073510818914	36338892
colitis/chemically induced	melanoma/drug therapy	0.1980073510818914	32414860
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.8225783874580066	36159840
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.8225783874580066	36377339
neoplasms/drug therapy	AHR	0.12500000000000003	35236743
inflammatory bowel diseases/drug therapy	proton pump inhibitors/adverse effects	0.03125	35277350
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.940712711772568	33506015
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.940712711772568	35236743
ipilimumab/adverse effects	CD274	0.4266665414911556	32934876
ipilimumab/adverse effects	CD274	0.4266665414911556	35917654
colitis/chemically induced	hepatitis autoimmune/etiology	0.7291666666666666	32130969
colitis	CD274	0.11391467687750607	35432346
colitis	CD274	0.11391467687750607	33314269
colitis/chemically induced	piperidines/therapeutic use	0.9287280701754386	33096100
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.8225783874580066	33555016
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.8225783874580066	35277350
colitis/chemically induced	adrenal cortex hormones/pharmacology	0.7291666666666666	33268234
colitis/chemically induced	drug-related side effects and adverse reactions/diagnosis	0.7291666666666666	35191192
colitis	CTLA4	0.07497110139796988	35432346
colitis	CTLA4	0.07497110139796988	33314269
ipilimumab/adverse effects	CTLA4	0.08200775084647441	35191192
ipilimumab/adverse effects	CTLA4	0.08200775084647441	32934876
ipilimumab/adverse effects	CTLA4	0.08200775084647441	35917654
colitis/chemically induced	immunocompromised host	0.7291666666666666	34956219
colitis/chemically induced	colon/immunology	0.5296052631578947	33459466
colitis/chemically induced	colon/immunology	0.5296052631578947	34777387
tongue neoplasms/drug therapy	SNCA	0.03125	33476895
colitis/chemically induced	dose-response relationship drug	0.8225783874580066	33290513
colitis/chemically induced	dose-response relationship drug	0.8225783874580066	32540858
colitis/chemically induced	neutrophils/drug effects	0.7291666666666666	32567084
colitis/chemically induced	myasthenia gravis/chemically induced	0.7291666666666666	32130969
neoplasms/drug therapy	IL22	0.23552631578947367	35236743
colitis/chemically induced	antibodies monoclonal/adverse effects	0.7291666666666666	32567084
colitis/chemically induced	immunosuppressive agents/pharmacology	0.7291666666666666	32414860
colitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.9287280701754386	32130969
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9682927699873767	32540858
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9682927699873767	32567084
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9682927699873767	32702598
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9682927699873767	33506015
colitis	PDCD1	0.27738142542354516	35432346
colitis	PDCD1	0.27738142542354516	33314269
colitis/chemically induced	drug-related side effects and adverse reactions	0.5296052631578947	32162824
colitis/chemically induced	drug-related side effects and adverse reactions	0.5296052631578947	32418993
ipilimumab/adverse effects	PDCD1	0.7374156126320984	35191192
ipilimumab/adverse effects	PDCD1	0.7374156126320984	35917654
colitis/chemically induced	gastrointestinal neoplasms/drug therapy	0.7291666666666666	36159840
ipilimumab/adverse effects	SNCA	0.2581536954087347	32934876
colitis/chemically induced	melanoma/complications	0.8225783874580066	32418993
colitis/chemically induced	melanoma/complications	0.8225783874580066	32567084
colitis/chemically induced	cell line tumor	0.9287280701754386	33495297
colitis/chemically induced	adenocarcinoma of lung/drug therapy	0.7291666666666666	32389505
adrenal insufficiency/chemically induced	axitinib/administration & dosage	0.010416666666666668	32130969
colitis/chemically induced	trinitrobenzenesulfonic acid/adverse effects	0.7291666666666666	33506015
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.8225783874580066	32567084
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.8225783874580066	32702598
colitis/chemically induced	t-lymphocyte subsets/immunology	0.7291666666666666	34777387
colitis/chemically induced	mucositis/chemically induced	0.7291666666666666	32414860
feces	diarrhea/chemically induced	0.15624999999999997	33290513
inflammatory bowel diseases/drug therapy	ipilimumab/therapeutic use	0.09178331466965287	35277350
colitis/chemically induced	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.7291666666666666	33495297
colitis/chemically induced	gastritis/complications	0.7291666666666666	36377339
colitis/chemically induced	infliximab/administration & dosage	0.7291666666666666	32418993
feces	colitis/chemically induced	0.7291666666666666	33290513
adrenal insufficiency/chemically induced	colitis/chemically induced	0.7291666666666666	32130969
inflammatory bowel diseases/drug therapy	CD274	0.06270996640537514	33555016
inflammatory bowel diseases/drug therapy	CD274	0.06270996640537514	33314269
gastritis/chemically induced	colitis/chemically induced	0.7291666666666666	32621258
inflammatory bowel diseases/drug therapy	CD4	0.06184210526315789	33555016
inflammatory bowel diseases/drug therapy	CD68	0.06184210526315789	33555016
encephalitis/diagnostic imaging	colitis/diagnostic imaging	0.010416666666666668	33375984
inflammatory bowel diseases/drug therapy	CD8A	0.1497410414333707	33555016
adrenal insufficiency/chemically induced	hypophysitis/chemically induced	0.010416666666666668	32130969
inflammatory bowel diseases/drug therapy	CTLA4	0.04034154535274355	33555016
inflammatory bowel diseases/drug therapy	CTLA4	0.04034154535274355	33314269
colitis/chemically induced	biological products/therapeutic use	0.7291666666666666	34380976
colitis/chemically induced	enterocolitis/chemically induced	0.9287280701754386	36377339
colitis/chemically induced	lung neoplasms	0.7291666666666666	31864555
colitis/chemically induced	cd8-positive t-lymphocytes	0.7291666666666666	34106395
adrenal insufficiency/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
colitis/chemically induced	beclomethasone/adverse effects	0.7291666666666666	36113896
inflammatory bowel diseases/drug therapy	PDCD1	0.1651735722284434	33555016
inflammatory bowel diseases/drug therapy	PDCD1	0.1651735722284434	33314269
colitis/chemically induced	hepatitis/diagnosis	0.7291666666666666	32185493
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7165980324868451	32422528
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7165980324868451	32702598
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7165980324868451	32567084
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7165980324868451	36338892
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7165980324868451	32434876
colitis/chemically induced	ipilimumab/therapeutic use	0.3831187010078388	35124713
colitis/chemically induced	ipilimumab/therapeutic use	0.3831187010078388	32130969
colitis/chemically induced	ipilimumab/therapeutic use	0.3831187010078388	35277350
adrenal insufficiency/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
colitis/chemically induced	drugs investigational/administration & dosage	0.7291666666666666	32540858
colitis/chemically induced	biomarkers/analysis	0.9818029115341546	26448188
colitis/chemically induced	cytomegalovirus infections/complications	0.7291666666666666	35307927
antibodies monoclonal humanized/therapeutic use	steroids/adverse effects	0.010416666666666668	33454238
colitis/chemically induced	butyrates/metabolism	0.7291666666666666	33741313
colitis/chemically induced	inflammatory bowel diseases/complications	0.9287280701754386	34158318
adrenal insufficiency/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
colitis/chemically induced	rna	0.7291666666666666	35977003
colitis/chemically induced	steroids/therapeutic use	0.5296052631578947	33290513
colitis/chemically induced	steroids/therapeutic use	0.5296052631578947	31864555
feces	dose-response relationship drug	0.03125	33290513
colitis/chemically induced	piperazines/administration & dosage	0.7291666666666666	33495297
adrenal insufficiency/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
colitis/chemically induced	inflammation	0.7291666666666666	32888202
antibodies monoclonal humanized/therapeutic use	colitis/chemically induced	0.7291666666666666	33454238
colitis/chemically induced	prednisone/therapeutic use	0.7291666666666666	34956219
colitis/chemically induced	ACAD8	0.5296052631578947	32418993
colitis/chemically induced	ACAD8	0.5296052631578947	33506015
adrenal insufficiency/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
colitis/chemically induced	AHR	0.7291666666666666	35236743
colitis/chemically induced	APC	0.5296052631578947	33495297
colitis/chemically induced	APC	0.5296052631578947	33462141
colitis/chemically induced	ARG1	0.7291666666666666	33495297
colitis/chemically induced	BTLA	0.7291666666666666	36159840
encephalitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
colitis/chemically induced	CD274	0.6205932764872848	36159840
colitis/chemically induced	CD274	0.6205932764872848	32389505
colitis/chemically induced	CD274	0.6205932764872848	34992611
colitis/chemically induced	CD274	0.6205932764872848	32702598
colitis/chemically induced	CD274	0.6205932764872848	33555016
colitis/chemically induced	CD274	0.6205932764872848	33173388
colitis/chemically induced	CD274	0.6205932764872848	34158318
colitis/chemically induced	CD274	0.6205932764872848	35917654
colitis/chemically induced	CD274	0.6205932764872848	32540858
colitis/chemically induced	CD274	0.6205932764872848	32934876
colitis/chemically induced	CD274	0.6205932764872848	33462141
colitis/chemically induced	CD28	0.7291666666666666	36159840
colitis/chemically induced	CD4	0.9287280701754386	33555016
colitis/chemically induced	CD68	0.9287280701754386	33555016
colitis/chemically induced	CD8A	0.9818029115341546	33555016
colitis/chemically induced	CD8A	0.9818029115341546	33462141
colitis/chemically induced	CHI3L1	0.7291666666666666	36096534
colitis/chemically induced	CRP	0.7291666666666666	32418993
colitis/chemically induced	CSF2	0.7291666666666666	36159840
colitis/chemically induced	CTLA4	0.8101065990923317	34992611
colitis/chemically induced	CTLA4	0.8101065990923317	32702598
colitis/chemically induced	CTLA4	0.8101065990923317	33555016
colitis/chemically induced	CTLA4	0.8101065990923317	35977003
colitis/chemically induced	CTLA4	0.8101065990923317	32567084
colitis/chemically induced	CTLA4	0.8101065990923317	35917654
colitis/chemically induced	CTLA4	0.8101065990923317	35191192
colitis/chemically induced	CTLA4	0.8101065990923317	32934876
colitis/chemically induced	CXCL10	0.7291666666666666	35977003
colitis/chemically induced	CXCL8	0.7291666666666666	36096534
adrenal insufficiency/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
colitis/chemically induced	CXCL9	0.7291666666666666	35977003
colitis/chemically induced	HAVCR2	0.7291666666666666	36159840
colitis/chemically induced	IL15	0.7291666666666666	36159840
colitis/chemically induced	IL17A	0.5296052631578947	33462141
colitis/chemically induced	IL17A	0.5296052631578947	36096534
colitis/chemically induced	IL17C	0.7291666666666666	36159840
colitis/chemically induced	IL21	0.7291666666666666	36159840
feces	steroids/therapeutic use	0.020833333333333332	33290513
colitis/chemically induced	IL22	0.5296052631578947	36159840
colitis/chemically induced	IL22	0.5296052631578947	35236743
colitis/chemically induced	IL4	0.7291666666666666	36159840
colitis/chemically induced	IL6	0.5296052631578947	36159840
colitis/chemically induced	IL6	0.5296052631578947	36096534
colitis/chemically induced	LIF	0.7291666666666666	36159840
colitis/chemically induced	LTF	0.7291666666666666	32584703
colitis/chemically induced	MIR15B	0.7291666666666666	33462141
colitis/chemically induced	NRF1	0.7291666666666666	33462141
colitis/chemically induced	PARP1	0.7291666666666666	33495297
colitis/chemically induced	PDCD1	0.9212638973672553	36159840
colitis/chemically induced	PDCD1	0.9212638973672553	33495297
colitis/chemically induced	PDCD1	0.9212638973672553	35801666
colitis/chemically induced	PDCD1	0.9212638973672553	34992611
colitis/chemically induced	PDCD1	0.9212638973672553	32702598
colitis/chemically induced	PDCD1	0.9212638973672553	33555016
colitis/chemically induced	PDCD1	0.9212638973672553	33906378
colitis/chemically induced	PDCD1	0.9212638973672553	35977003
colitis/chemically induced	PDCD1	0.9212638973672553	33173388
colitis/chemically induced	PDCD1	0.9212638973672553	32567084
colitis/chemically induced	PDCD1	0.9212638973672553	34158318
colitis/chemically induced	PDCD1	0.9212638973672553	35917654
colitis/chemically induced	PDCD1	0.9212638973672553	35191192
colitis/chemically induced	PDCD1	0.9212638973672553	32540858
colitis/chemically induced	PDCD1	0.9212638973672553	33462141
colitis/chemically induced	PDCD1	0.9212638973672553	33506015
colitis/chemically induced	SNCA	0.8225783874580066	32934876
colitis/chemically induced	SNCA	0.8225783874580066	32641348
colitis/chemically induced	TCIM	0.7291666666666666	35977003
colitis/chemically induced	TIPARP	0.7291666666666666	33495297
colitis/chemically induced	TNF	0.3831187010078388	32162824
colitis/chemically induced	TNF	0.3831187010078388	35977003
colitis/chemically induced	TNF	0.3831187010078388	32641348
colitis/chemically induced	antineoplastic agents/adverse effects	0.7291666666666666	26448188
colitis/chemically induced	intestinal mucosa/chemistry	0.7291666666666666	26448188
colitis/chemically induced	leukemia lymphocytic chronic b-cell/drug therapy	0.7291666666666666	26448188
protein kinase inhibitors/therapeutic use	neoplasms/drug therapy	0.125	33096100
colitis/chemically induced	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.7291666666666666	26448188
colitis/chemically induced	purines/adverse effects	0.7291666666666666	26448188
colitis/chemically induced	colon/chemistry	0.7291666666666666	26448188
immune checkpoint inhibitors/administration & dosage	ht29 cells	0.041666666666666664	33462141
colitis/chemically induced	lymphocytosis/chemically induced	0.7291666666666666	26448188
colitis/chemically induced	protein kinase inhibitors/adverse effects	0.7291666666666666	26448188
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.27601024696263654	33495297
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.27601024696263654	32540858
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.27601024696263654	32418993
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.27601024696263654	33462141
protein kinase inhibitors/therapeutic use	ipilimumab/adverse effects	0.09375000000000001	33096100
colitis/chemically induced	apoptosis/drug effects	0.7291666666666666	26448188
immune checkpoint inhibitors/administration & dosage	phthalazines/administration & dosage	0.041666666666666664	33495297
colitis/chemically induced	quinazolinones/adverse effects	0.7291666666666666	26448188
colitis/chemically induced	lymphoma non-hodgkin/drug therapy	0.7291666666666666	26448188
colitis/chemically induced	PIK3CD	0.7291666666666666	26448188
immune checkpoint inhibitors/administration & dosage	dextran sulfate/adverse effects	0.041666666666666664	33495297
protein kinase inhibitors/therapeutic use	colitis/chemically induced	0.7291666666666666	33096100
immune checkpoint inhibitors/administration & dosage	colorectal neoplasms/drug therapy	0.041666666666666664	33462141
phthalazines/administration & dosage	dextran sulfate/adverse effects	0.010416666666666668	33495297
immune checkpoint inhibitors/administration & dosage	carcinoma non-small-cell lung/complications	0.041666666666666664	32418993
immune checkpoint inhibitors/administration & dosage	b7-h1 antigen/genetics	0.041666666666666664	33462141
immune checkpoint inhibitors/administration & dosage	colonic neoplasms/drug therapy	0.041666666666666664	33495297
protein kinase inhibitors/therapeutic use	piperidines/therapeutic use	0.020833333333333332	33096100
phthalazines/administration & dosage	colonic neoplasms/drug therapy	0.010416666666666668	33495297
immune checkpoint inhibitors/administration & dosage	dose-response relationship drug	0.12108062709966406	32540858
immune checkpoint inhibitors/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.2980379053329963	32540858
immune checkpoint inhibitors/administration & dosage	drug-related side effects and adverse reactions	0.08201754385964913	32418993
immune checkpoint inhibitors/administration & dosage	melanoma/complications	0.12108062709966406	32418993
immune checkpoint inhibitors/administration & dosage	cell line tumor	0.08201754385964913	33495297
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5296052631578946	35124713
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5296052631578946	34992611
immune checkpoint inhibitors/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.041666666666666664	33495297
immune checkpoint inhibitors/administration & dosage	infliximab/administration & dosage	0.041666666666666664	32418993
phthalazines/administration & dosage	cell line tumor	0.020833333333333332	33495297
immune checkpoint inhibitors/administration & dosage	drugs investigational/administration & dosage	0.041666666666666664	32540858
immune checkpoint inhibitors/administration & dosage	piperazines/administration & dosage	0.041666666666666664	33495297
phthalazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010416666666666668	33495297
immune checkpoint inhibitors/administration & dosage	ACAD8	0.08201754385964913	32418993
immune checkpoint inhibitors/administration & dosage	APC	0.0013157894736842105	33495297
immune checkpoint inhibitors/administration & dosage	APC	0.0013157894736842105	33462141
skin neoplasms/immunology	colitis/chemically induced	0.7291666666666666	34956219
immune checkpoint inhibitors/administration & dosage	ARG1	0.041666666666666664	33495297
immune checkpoint inhibitors/administration & dosage	CD274	0.11391467687750607	32540858
immune checkpoint inhibitors/administration & dosage	CD274	0.11391467687750607	33462141
immune checkpoint inhibitors/administration & dosage	CD8A	0.19545388866813576	33462141
immune checkpoint inhibitors/administration & dosage	CRP	0.041666666666666664	32418993
immune checkpoint inhibitors/administration & dosage	IL17A	0.08201754385964913	33462141
skin neoplasms/immunology	melanoma/immunology	0.010416666666666668	34956219
phthalazines/administration & dosage	piperazines/administration & dosage	0.010416666666666668	33495297
immune checkpoint inhibitors/administration & dosage	MIR15B	0.041666666666666664	33462141
immune checkpoint inhibitors/administration & dosage	NRF1	0.041666666666666664	33462141
phthalazines/administration & dosage	APC	0.020833333333333332	33495297
immune checkpoint inhibitors/administration & dosage	PARP1	0.041666666666666664	33495297
phthalazines/administration & dosage	ARG1	0.010416666666666668	33495297
immune checkpoint inhibitors/administration & dosage	PDCD1	0.052965719033341754	33495297
immune checkpoint inhibitors/administration & dosage	PDCD1	0.052965719033341754	32540858
immune checkpoint inhibitors/administration & dosage	PDCD1	0.052965719033341754	33462141
colitis microscopic/chemically induced	inflammatory bowel diseases/complications	0.041447368421052636	32401685
immune checkpoint inhibitors/administration & dosage	TIPARP	0.041666666666666664	33495297
endometrial neoplasms/drug therapy	PDCD1	0.26041666666666663	35801666
skin neoplasms/immunology	immunocompromised host	0.010416666666666668	34956219
carcinoma non-small-cell lung/drug therapy	ipilimumab/therapeutic use	0.0618421052631579	35124713
dysbiosis/etiology	neoplasms/complications	0.03125	34162429
phthalazines/administration & dosage	PARP1	0.010416666666666668	33495297
phthalazines/administration & dosage	PDCD1	0.26041666666666663	33495297
phthalazines/administration & dosage	TIPARP	0.010416666666666668	33495297
carcinoma non-small-cell lung/drug therapy	CD274	0.2894736842105262	34992611
colitis microscopic/chemically induced	PDCD1	0.45504385964912286	32401685
carcinoma non-small-cell lung/drug therapy	CTLA4	0.23552631578947367	34992611
receptors antigen t-cell/genetics	t-lymphocytes regulatory/cytology	0.010416666666666668	32603654
dysbiosis/etiology	colitis/etiology	0.020833333333333332	34162429
carcinoma non-small-cell lung/drug therapy	PDCD1	0.45504385964912286	34992611
skin neoplasms/immunology	prednisone/therapeutic use	0.010416666666666668	34956219
colitis/drug therapy	diarrhea/chemically induced	0.40285554311310195	33436487
receptors antigen t-cell/genetics	chemokines/metabolism	0.010416666666666668	32603654
receptors antigen t-cell/genetics	multigene family	0.010416666666666668	32603654
colitis/drug therapy	neoplasms/therapy	0.03125	32780984
dysbiosis/etiology	antineoplastic agents immunological/adverse effects	0.07291666666666667	34162429
dysbiosis/etiology	anti-bacterial agents/pharmacology	0.010416666666666668	34162429
colitis/drug therapy	receptors antigen t-cell/genetics	0.03125	32603654
receptors antigen t-cell/genetics	CTLA4	0.125	32603654
neoplasms/complications	colitis/etiology	0.06184210526315789	34162429
neoplasms/complications	programmed cell death 1 receptor/antagonists & inhibitors	0.23197088465845458	32960847
colitis/drug therapy	t-lymphocytes regulatory/cytology	0.03125	32603654
receptors antigen t-cell/genetics	PDCD1	0.26041666666666663	32603654
azoxymethane/adverse effects	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33495297
colitis/drug therapy	feces/chemistry	0.09178331466965287	33436487
azoxymethane/adverse effects	colitis/chemically induced	0.7291666666666666	33495297
azoxymethane/adverse effects	phthalazines/administration & dosage	0.010416666666666668	33495297
azoxymethane/adverse effects	dextran sulfate/adverse effects	0.010416666666666668	33495297
colitis/drug therapy	leukocyte l1 antigen complex/analysis	0.09178331466965287	33436487
neoplasms/complications	antineoplastic agents immunological/adverse effects	0.20517917133258673	34162429
steroids/adverse effects	colitis/chemically induced	0.7291666666666666	33454238
angiogenesis inhibitors/therapeutic use	myocarditis/chemically induced	0.010416666666666668	32130969
colitis/drug therapy	chemokines/metabolism	0.03125	32603654
azoxymethane/adverse effects	colonic neoplasms/drug therapy	0.010416666666666668	33495297
neoplasms/complications	inflammatory bowel diseases/complications	0.06184210526315789	34158318
angiogenesis inhibitors/therapeutic use	hepatitis autoimmune/etiology	0.010416666666666668	32130969
clostridium infections/chemically induced	colitis/chemically induced	0.7291666666666666	34107499
neoplasms/complications	anti-bacterial agents/pharmacology	0.03125	34162429
colitis/drug therapy	multigene family	0.03125	32603654
angiogenesis inhibitors/therapeutic use	myasthenia gravis/chemically induced	0.010416666666666668	32130969
angiogenesis inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
neoplasms/complications	CD274	0.06270996640537514	34158318
neoplasms/complications	CD274	0.06270996640537514	32960847
clostridium infections/chemically induced	anti-bacterial agents/adverse effects	0.010416666666666668	34107499
colitis/drug therapy	biomarkers/analysis	0.09178331466965287	33436487
angiogenesis inhibitors/therapeutic use	ipilimumab/therapeutic use	0.03125	32130969
azoxymethane/adverse effects	cell line tumor	0.020833333333333332	33495297
azoxymethane/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010416666666666668	33495297
neoplasms/complications	PDCD1	0.1651735722284434	34158318
neoplasms/complications	PDCD1	0.1651735722284434	32960847
colitis/drug therapy	CTLA4	0.33311870100783875	32603654
azoxymethane/adverse effects	piperazines/administration & dosage	0.010416666666666668	33495297
colitis/drug therapy	PDCD1	0.5999790033594625	32603654
azoxymethane/adverse effects	APC	0.020833333333333332	33495297
azoxymethane/adverse effects	ARG1	0.010416666666666668	33495297
abdominal pain/chemically induced	antineoplastic agents immunological/therapeutic use	0.03125	36377339
recurrence	diarrhea/chemically induced	0.40285554311310195	26448188
azoxymethane/adverse effects	PARP1	0.010416666666666668	33495297
azoxymethane/adverse effects	PDCD1	0.26041666666666663	33495297
biomarkers/metabolism	adenocarcinoma of lung/drug therapy	0.010416666666666668	32389505
recurrence	colitis/chemically induced	0.9818029115341546	26448188
lymphocytes/drug effects	colitis/chemically induced	0.7291666666666666	32567084
azoxymethane/adverse effects	TIPARP	0.010416666666666668	33495297
myocarditis/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
myocarditis/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
abdominal pain/chemically induced	gastritis/complications	0.010416666666666668	36377339
myocarditis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
abdominal pain/chemically induced	enterocolitis/chemically induced	0.020833333333333332	36377339
biomarkers/metabolism	CD274	0.15624999999999997	32389505
recurrence	feces/chemistry	0.09178331466965287	36591847
recurrence	inflammatory bowel diseases	0.06184210526315789	35842365
myocarditis/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
gentian violet	colitis/chemically induced	0.7291666666666666	32888202
recurrence	leukocyte l1 antigen complex/analysis	0.09178331466965287	36591847
growth inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010416666666666668	34987517
growth inhibitors/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03125	34987517
recurrence	biomarkers/analysis	0.001959686450167973	26448188
recurrence	biomarkers/analysis	0.001959686450167973	36591847
growth inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010416666666666668	34987517
growth inhibitors/therapeutic use	colitis/etiology	0.020833333333333332	34987517
growth inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	34987517
growth inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34987517
colitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010416666666666668	33375984
growth inhibitors/therapeutic use	cell line tumor	0.020833333333333332	34987517
hypophysitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010416666666666668	32130969
hypophysitis/chemically induced	myocarditis/chemically induced	0.010416666666666668	32130969
growth inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010416666666666668	34987517
recurrence	antineoplastic agents/adverse effects	0.03125	26448188
hypophysitis/chemically induced	hepatitis autoimmune/etiology	0.010416666666666668	32130969
recurrence	intestinal mucosa/chemistry	0.03125	26448188
recurrence	leukemia lymphocytic chronic b-cell/drug therapy	0.03125	26448188
recurrence	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.03125	26448188
recurrence	purines/adverse effects	0.03125	26448188
recurrence	colon/chemistry	0.03125	26448188
gentian violet	inflammation	0.010416666666666668	32888202
recurrence	lymphocytosis/chemically induced	0.03125	26448188
hypophysitis/chemically induced	myasthenia gravis/chemically induced	0.010416666666666668	32130969
recurrence	protein kinase inhibitors/adverse effects	0.03125	26448188
growth inhibitors/therapeutic use	cytotoxicity immunologic	0.010416666666666668	34987517
recurrence	apoptosis/drug effects	0.03125	26448188
recurrence	quinazolinones/adverse effects	0.03125	26448188
hypophysitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
recurrence	lymphoma non-hodgkin/drug therapy	0.03125	26448188
recurrence	PIK3CD	0.03125	26448188
growth inhibitors/therapeutic use	CD8A	0.05208333333333334	34987517
recurrence	diarrhea/diagnosis	0.03125	36591847
recurrence	colitis microscopic/diagnosis	0.03125	36591847
antibodies monoclonal humanized	PDCD1	0.26041666666666663	35801666
growth inhibitors/therapeutic use	MTOR	0.010416666666666668	34987517
hypophysitis/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
growth inhibitors/therapeutic use	PDCD1	0.26041666666666663	34987517
dermatitis	rna	0.010416666666666668	35977003
t-lymphocytes cytotoxic/immunology	tumor microenvironment/drug effects	0.010416666666666668	33462141
t-lymphocytes regulatory/cytology	chemokines/metabolism	0.010416666666666668	32603654
ht29 cells	colitis/chemically induced	0.7291666666666666	33462141
t-lymphocytes regulatory/cytology	multigene family	0.010416666666666668	32603654
dermatitis	CTLA4	0.125	35977003
dermatitis	CXCL10	0.010416666666666668	35977003
ht29 cells	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
dermatitis	CXCL9	0.010416666666666668	35977003
t-lymphocytes cytotoxic/immunology	immune checkpoint inhibitors/administration & dosage	0.041666666666666664	33462141
t-lymphocytes cytotoxic/immunology	ht29 cells	0.010416666666666668	33462141
ht29 cells	b7-h1 antigen/genetics	0.010416666666666668	33462141
dermatitis	PDCD1	0.26041666666666663	35977003
t-lymphocytes cytotoxic/immunology	colitis/chemically induced	0.7291666666666666	33462141
dermatitis	TCIM	0.010416666666666668	35977003
dermatitis	TNF	0.03125	35977003
crohn disease/physiopathology	enterocolitis/chemically induced	0.020833333333333332	34821404
t-lymphocytes regulatory/cytology	CTLA4	0.125	32603654
t-lymphocytes cytotoxic/immunology	colorectal neoplasms/drug therapy	0.010416666666666668	33462141
colorectal neoplasms/drug therapy	b7-h1 antigen/genetics	0.010416666666666668	33462141
t-lymphocytes cytotoxic/immunology	b7-h1 antigen/genetics	0.010416666666666668	33462141
t-lymphocytes regulatory/cytology	PDCD1	0.26041666666666663	32603654
colonic neoplasms/drug therapy	cell line tumor	0.020833333333333332	33495297
colonic neoplasms/drug therapy	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010416666666666668	33495297
colorectal neoplasms/drug therapy	APC	0.020833333333333332	33462141
ht29 cells	APC	0.020833333333333332	33462141
colorectal neoplasms/drug therapy	CD274	0.15624999999999997	33462141
ht29 cells	CD274	0.15624999999999997	33462141
colorectal neoplasms/drug therapy	CD8A	0.05208333333333334	33462141
ht29 cells	CD8A	0.05208333333333334	33462141
crohn disease/immunology	graft vs host disease/immunology	0.010416666666666668	34338882
colorectal neoplasms/drug therapy	IL17A	0.020833333333333332	33462141
colonic neoplasms/drug therapy	piperazines/administration & dosage	0.010416666666666668	33495297
colorectal neoplasms/drug therapy	MIR15B	0.010416666666666668	33462141
colorectal neoplasms/drug therapy	NRF1	0.010416666666666668	33462141
crohn disease/immunology	cd8-positive t-lymphocytes/drug effects	0.020833333333333332	34338882
ht29 cells	IL17A	0.020833333333333332	33462141
colorectal neoplasms/drug therapy	PDCD1	0.26041666666666663	33462141
diarrhea/chemically induced	ipilimumab/adverse effects	0.4266665414911556	31595568
diarrhea/chemically induced	ipilimumab/adverse effects	0.4266665414911556	35917654
colonic neoplasms/drug therapy	APC	0.020833333333333332	33495297
crohn disease/immunology	phenotype	0.020833333333333332	34338882
colonic neoplasms/drug therapy	ARG1	0.010416666666666668	33495297
diarrhea/chemically induced	clostridium infections/chemically induced	0.15625000000000003	34107499
t-lymphocytes cytotoxic/immunology	APC	0.020833333333333332	33462141
ht29 cells	MIR15B	0.010416666666666668	33462141
t-lymphocytes cytotoxic/immunology	CD274	0.15624999999999997	33462141
ht29 cells	NRF1	0.010416666666666668	33462141
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	32641348
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	31609734
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	36113896
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	34107499
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	33173388
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	34158318
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	34380976
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	33290513
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	31595568
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	35917654
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	36096534
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	36377339
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	26448188
diarrhea/chemically induced	colitis/chemically induced	0.04392514941740006	32584703
ht29 cells	PDCD1	0.26041666666666663	33462141
t-lymphocytes cytotoxic/immunology	CD8A	0.05208333333333334	33462141
diarrhea/chemically induced	neoplasms/complications	0.402855543113102	34158318
diarrhea/chemically induced	abdominal pain/chemically induced	0.15625000000000003	36377339
crohn disease/immunology	CD4	0.020833333333333332	34338882
crohn disease/immunology	CD68	0.020833333333333332	34338882
crohn disease/immunology	CD8A	0.05208333333333334	34338882
colonic neoplasms/drug therapy	PARP1	0.010416666666666668	33495297
colonic neoplasms/drug therapy	PDCD1	0.26041666666666663	33495297
diarrhea/chemically induced	anti-bacterial agents/adverse effects	0.15625000000000003	34107499
colonic neoplasms/drug therapy	TIPARP	0.010416666666666668	33495297
anti-bacterial agents	colitis/chemically induced	0.7291666666666666	36043345
diarrhea/chemically induced	feces/chemistry	0.402855543113102	33436487
diarrhea/chemically induced	melanoma/drug therapy	0.5808263665190849	32641348
diarrhea/chemically induced	antineoplastic agents immunological/therapeutic use	0.402855543113102	36377339
diarrhea/chemically induced	dose-response relationship drug	0.402855543113102	33290513
intestinal mucosa/immunology	colon/immunology	0.020833333333333332	33459466
diarrhea/chemically induced	leukocyte l1 antigen complex/analysis	0.402855543113102	33436487
piperidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34147519
diarrhea/chemically induced	gastritis/complications	0.15625000000000003	36377339
diarrhea/chemically induced	biological products/therapeutic use	0.15625000000000003	34380976
diarrhea/chemically induced	enterocolitis/chemically induced	0.28947368421052627	36377339
glucocorticoids/pharmacology	melanoma/drug therapy	0.05208333333333334	32414860
piperidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.0618421052631579	34147519
diarrhea/chemically induced	beclomethasone/adverse effects	0.15625000000000003	36113896
diarrhea/chemically induced	biomarkers/analysis	0.06270996640537516	26448188
diarrhea/chemically induced	biomarkers/analysis	0.06270996640537516	33436487
diarrhea/chemically induced	inflammatory bowel diseases/complications	0.28947368421052627	34158318
glucocorticoids/pharmacology	immunosuppressive agents/pharmacology	0.010416666666666668	32414860
diarrhea/chemically induced	steroids/therapeutic use	0.28947368421052627	33290513
piperidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.041447368421052636	34147519
piperidines/therapeutic use	phenotype	0.041447368421052636	34147519
diarrhea/chemically induced	CD274	0.42737126655335067	35917654
diarrhea/chemically induced	CD274	0.42737126655335067	33173388
diarrhea/chemically induced	CD274	0.42737126655335067	34158318
glucocorticoids/pharmacology	mucositis/chemically induced	0.010416666666666668	32414860
diarrhea/chemically induced	CHI3L1	0.15625000000000003	36096534
diarrhea/chemically induced	CTLA4	0.8867810643744477	35917654
diarrhea/chemically induced	CXCL8	0.15625000000000003	36096534
piperidines/therapeutic use	CD8A	0.10197368421052633	34147519
diarrhea/chemically induced	IL17A	0.28947368421052627	36096534
piperidines/therapeutic use	CTLA4	0.23552631578947367	34147519
diarrhea/chemically induced	IL6	0.28947368421052627	36096534
diarrhea/chemically induced	LTF	0.15625000000000003	32584703
diarrhea/chemically induced	PDCD1	0.8137514751315049	35917654
diarrhea/chemically induced	PDCD1	0.8137514751315049	33173388
diarrhea/chemically induced	PDCD1	0.8137514751315049	34158318
diarrhea/chemically induced	SNCA	0.402855543113102	32641348
disease susceptibility	postoperative complications	0.010416666666666668	32028372
diarrhea/chemically induced	TNF	0.402855543113102	32641348
diarrhea/chemically induced	antineoplastic agents/adverse effects	0.15625000000000003	26448188
piperidines/therapeutic use	PDCD1	0.45504385964912286	34147519
diarrhea/chemically induced	intestinal mucosa/chemistry	0.15625000000000003	26448188
diarrhea/chemically induced	leukemia lymphocytic chronic b-cell/drug therapy	0.15625000000000003	26448188
diarrhea/chemically induced	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.15625000000000003	26448188
diarrhea/chemically induced	purines/adverse effects	0.15625000000000003	26448188
diarrhea/chemically induced	colon/chemistry	0.15625000000000003	26448188
diarrhea/chemically induced	lymphocytosis/chemically induced	0.15625000000000003	26448188
oropharyngeal neoplasms/drug therapy	PDCD1	0.26041666666666663	33906378
diarrhea/chemically induced	protein kinase inhibitors/adverse effects	0.15625000000000003	26448188
diarrhea/chemically induced	apoptosis/drug effects	0.15625000000000003	26448188
diarrhea/chemically induced	quinazolinones/adverse effects	0.15625000000000003	26448188
diarrhea/chemically induced	lymphoma non-hodgkin/drug therapy	0.15625000000000003	26448188
diarrhea/chemically induced	PIK3CD	0.15625000000000003	26448188
lymphocytes tumor-infiltrating/immunology	colitis/etiology	0.020833333333333332	34987517
lymphocytes tumor-infiltrating/immunology	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	34987517
immunologic factors	colitis/chemically induced	0.9287280701754386	33566405
lymphocytes tumor-infiltrating/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34987517
vitamin d/administration & dosage	neutrophils/drug effects	0.010416666666666668	32567084
vitamin d/administration & dosage	antibodies monoclonal/adverse effects	0.010416666666666668	32567084
vitamin d/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32567084
lymphocytes tumor-infiltrating/immunology	cell line tumor	0.020833333333333332	34987517
vitamin d/administration & dosage	melanoma/complications	0.03125	32567084
vitamin d/administration & dosage	ctla-4 antigen/antagonists & inhibitors	0.03125	32567084
lymphocytes tumor-infiltrating/immunology	cd8-positive t-lymphocytes/immunology	0.010416666666666668	34987517
dextran sulfate/adverse effects	colonic neoplasms/drug therapy	0.010416666666666668	33495297
vitamin d/administration & dosage	antineoplastic agents immunological/adverse effects	0.07291666666666667	32567084
phosphatidylinositol 3-kinases/metabolism	antineoplastic agents immunological/therapeutic use	0.03125	34987517
phosphatidylinositol 3-kinases/metabolism	lymphocytes tumor-infiltrating/immunology	0.010416666666666668	34987517
lymphocytes tumor-infiltrating/immunology	cytotoxicity immunologic	0.010416666666666668	34987517
phosphatidylinositol 3-kinases/metabolism	colitis/etiology	0.020833333333333332	34987517
phosphatidylinositol 3-kinases/metabolism	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	34987517
vitamin d/administration & dosage	CTLA4	0.125	32567084
phosphatidylinositol 3-kinases/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	34987517
lymphocytes tumor-infiltrating/immunology	CD8A	0.05208333333333334	34987517
phosphatidylinositol 3-kinases/metabolism	cell line tumor	0.020833333333333332	34987517
dextran sulfate/adverse effects	cell line tumor	0.020833333333333332	33495297
vitamin d/administration & dosage	PDCD1	0.26041666666666663	32567084
interleukin-23/antagonists & inhibitors	interleukin-12/antagonists & inhibitors	0.010416666666666668	33567198
dextran sulfate/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010416666666666668	33495297
phosphatidylinositol 3-kinases/metabolism	cd8-positive t-lymphocytes/immunology	0.010416666666666668	34987517
lymphocytes tumor-infiltrating/immunology	MTOR	0.010416666666666668	34987517
lymphocytes tumor-infiltrating/immunology	PDCD1	0.26041666666666663	34987517
phosphatidylinositol 3-kinases/metabolism	cytotoxicity immunologic	0.010416666666666668	34987517
carcinoma non-small-cell lung/complications	drug-related side effects and adverse reactions	0.020833333333333332	32418993
dextran sulfate/adverse effects	piperazines/administration & dosage	0.010416666666666668	33495297
phosphatidylinositol 3-kinases/metabolism	CD8A	0.05208333333333334	34987517
carcinoma non-small-cell lung/complications	melanoma/complications	0.03125	32418993
dextran sulfate/adverse effects	APC	0.020833333333333332	33495297
dextran sulfate/adverse effects	ARG1	0.010416666666666668	33495297
phosphatidylinositol 3-kinases/metabolism	MTOR	0.010416666666666668	34987517
carcinoma non-small-cell lung/complications	infliximab/administration & dosage	0.010416666666666668	32418993
phosphatidylinositol 3-kinases/metabolism	PDCD1	0.26041666666666663	34987517
dextran sulfate/adverse effects	PARP1	0.010416666666666668	33495297
carcinoma non-small-cell lung/complications	ACAD8	0.020833333333333332	32418993
dextran sulfate/adverse effects	PDCD1	0.26041666666666663	33495297
dextran sulfate/adverse effects	TIPARP	0.010416666666666668	33495297
carcinoma non-small-cell lung/complications	CRP	0.010416666666666668	32418993
colitis ulcerative/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33476895
proton pump inhibitors/adverse effects	colitis/chemically induced	0.7291666666666666	35277350
colitis ulcerative/chemically induced	antineoplastic agents immunological/adverse effects	0.07291666666666667	33476895
melanoma/immunology	immunocompromised host	0.010416666666666668	34956219
colitis ulcerative/chemically induced	SNCA	0.03125	33476895
programmed cell death 1 receptor/antagonists & inhibitors	melanoma/complications	0.2319708846584546	32567084
programmed cell death 1 receptor/antagonists & inhibitors	cell line tumor	0.16052631578947368	34987517
programmed cell death 1 receptor/antagonists & inhibitors	trinitrobenzenesulfonic acid/adverse effects	0.08333333333333334	33506015
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.0003919372900335946	32567084
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.0003919372900335946	32702598
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.0003919372900335946	34147519
melanoma/immunology	prednisone/therapeutic use	0.010416666666666668	34956219
feces/chemistry	dose-response relationship drug	0.09178331466965287	21694533
cytomegalovirus infections/diagnosis	antineoplastic agents immunological/adverse effects	0.07291666666666667	32434876
feces/chemistry	leukocyte l1 antigen complex/analysis	6.998880179171334e-06	36591847
feces/chemistry	leukocyte l1 antigen complex/analysis	6.998880179171334e-06	21694533
feces/chemistry	leukocyte l1 antigen complex/analysis	6.998880179171334e-06	33436487
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/immunology	0.08333333333333334	34987517
proton pump inhibitors/adverse effects	ipilimumab/therapeutic use	0.03125	35277350
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.011618589114352483	32567084
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.011618589114352483	32702598
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.011618589114352483	33476895
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.16052631578947368	34147519
programmed cell death 1 receptor/antagonists & inhibitors	drugs investigational/administration & dosage	0.08333333333333334	32540858
programmed cell death 1 receptor/antagonists & inhibitors	phenotype	0.16052631578947368	34147519
feces/chemistry	biomarkers/analysis	0.001959686450167973	36591847
feces/chemistry	biomarkers/analysis	0.001959686450167973	33436487
programmed cell death 1 receptor/antagonists & inhibitors	cytotoxicity immunologic	0.08333333333333334	34987517
programmed cell death 1 receptor/antagonists & inhibitors	ACAD8	0.16052631578947368	33506015
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.10710167615597627	32540858
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.10710167615597627	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.10710167615597627	32960847
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.05387717675316876	34987517
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.05387717675316876	34147519
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.059016889508103444	32567084
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.059016889508103444	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.059016889508103444	34147519
drug-related side effects and adverse reactions/diagnosis	CTLA4	0.125	35191192
programmed cell death 1 receptor/antagonists & inhibitors	MTOR	0.08333333333333334	34987517
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	34147519
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	32702598
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	32567084
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	32960847
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	32540858
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	34987517
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00026554302502263915	33506015
programmed cell death 1 receptor/antagonists & inhibitors	SNCA	0.2319708846584546	33476895
feces/chemistry	diarrhea/etiology	0.03125	21694533
drug-related side effects and adverse reactions/diagnosis	PDCD1	0.26041666666666663	35191192
feces/chemistry	gastrointestinal hemorrhage/etiology	0.03125	21694533
feces/chemistry	prednisolone/administration & dosage	0.03125	21694533
feces/chemistry	glucocorticoids/administration & dosage	0.03125	21694533
feces/chemistry	diarrhea/diagnosis	0.03125	36591847
feces/chemistry	abdominal pain/etiology	0.03125	21694533
b7-h1 antigen/genetics	APC	0.020833333333333332	33462141
feces/chemistry	colitis microscopic/diagnosis	0.03125	36591847
b7-h1 antigen/genetics	CD274	0.15624999999999997	33462141
b7-h1 antigen/genetics	CD8A	0.05208333333333334	33462141
b7-h1 antigen/genetics	IL17A	0.020833333333333332	33462141
paclitaxel/therapeutic use	colitis ulcerative/chemically induced	0.010416666666666668	33476895
melanoma/drug therapy	immunosuppressive agents/pharmacology	0.05208333333333335	32414860
drug-related side effects and adverse reactions	melanoma/complications	0.0618421052631579	32418993
melanoma/drug therapy	drug-related side effects and adverse reactions	0.10197368421052633	32162824
b7-h1 antigen/genetics	MIR15B	0.010416666666666668	33462141
b7-h1 antigen/genetics	NRF1	0.010416666666666668	33462141
drug-related side effects and adverse reactions	infliximab/administration & dosage	0.020833333333333336	32418993
b7-h1 antigen/genetics	PDCD1	0.26041666666666663	33462141
melanoma/drug therapy	mucositis/chemically induced	0.05208333333333335	32414860
paclitaxel/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	33476895
melanoma/drug therapy	antineoplastic agents immunological/adverse effects	0.32092797363735504	36338892
drug-related side effects and adverse reactions	ACAD8	0.041447368421052636	32418993
lung neoplasms	steroids/therapeutic use	0.020833333333333332	31864555
paclitaxel/therapeutic use	antineoplastic agents immunological/adverse effects	0.07291666666666667	33476895
inflammatory bowel diseases	gastrointestinal tract/metabolism	0.020833333333333336	32298485
drug-related side effects and adverse reactions	CRP	0.020833333333333336	32418993
inflammatory bowel diseases	b7-h1 antigen/metabolism	0.020833333333333336	32298485
melanoma/drug therapy	SNCA	0.14974104143337066	32641348
melanoma/drug therapy	TNF	0.0064389697648376265	32162824
melanoma/drug therapy	TNF	0.0064389697648376265	32641348
inflammatory bowel diseases	CD274	0.2894736842105262	32298485
drug-related side effects and adverse reactions	TNF	0.0618421052631579	32162824
antineoplastic agents immunological/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.03125	34987517
antineoplastic agents immunological/therapeutic use	colitis/etiology	0.06184210526315789	34987517
antineoplastic agents immunological/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.06184210526315789	34987517
antineoplastic agents immunological/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.23197088465845458	34987517
antineoplastic agents immunological/therapeutic use	gastrointestinal neoplasms/drug therapy	0.03125	36159840
paclitaxel/therapeutic use	SNCA	0.03125	33476895
antineoplastic agents immunological/therapeutic use	cell line tumor	0.06184210526315789	34987517
cytotoxicity immunologic	CD8A	0.05208333333333334	34987517
antineoplastic agents immunological/therapeutic use	gastritis/complications	0.03125	36377339
inflammatory bowel diseases	PDCD1	0.45504385964912286	32298485
antineoplastic agents immunological/therapeutic use	enterocolitis/chemically induced	0.06184210526315789	36377339
antineoplastic agents immunological/therapeutic use	cd8-positive t-lymphocytes/immunology	0.03125	34987517
cytotoxicity immunologic	MTOR	0.010416666666666668	34987517
cytotoxicity immunologic	PDCD1	0.26041666666666663	34987517
antineoplastic agents immunological/therapeutic use	cytotoxicity immunologic	0.03125	34987517
endometrial neoplasms/drug therapy	antibodies monoclonal humanized	0.010416666666666668	35801666
antineoplastic agents immunological/therapeutic use	BTLA	0.03125	36159840
antineoplastic agents immunological/therapeutic use	CD274	0.40285554311310195	36159840
antineoplastic agents immunological/therapeutic use	CD28	0.03125	36159840
antineoplastic agents immunological/therapeutic use	CD8A	0.1497410414333707	34987517
antineoplastic agents immunological/therapeutic use	CSF2	0.03125	36159840
gastrointestinal neoplasms/drug therapy	BTLA	0.010416666666666668	36159840
gastrointestinal neoplasms/drug therapy	CD274	0.15624999999999997	36159840
gastrointestinal neoplasms/drug therapy	CD28	0.010416666666666668	36159840
antineoplastic agents immunological/therapeutic use	HAVCR2	0.03125	36159840
antineoplastic agents immunological/therapeutic use	IL15	0.03125	36159840
antineoplastic agents immunological/therapeutic use	IL17C	0.03125	36159840
graft vs host disease/immunology	cd8-positive t-lymphocytes/drug effects	0.020833333333333332	34338882
antineoplastic agents immunological/therapeutic use	IL21	0.03125	36159840
antineoplastic agents immunological/therapeutic use	IL22	0.06184210526315789	36159840
antineoplastic agents immunological/therapeutic use	IL4	0.03125	36159840
gastrointestinal neoplasms/drug therapy	CSF2	0.010416666666666668	36159840
antineoplastic agents immunological/therapeutic use	IL6	0.06184210526315789	36159840
graft vs host disease/immunology	phenotype	0.020833333333333332	34338882
antineoplastic agents immunological/therapeutic use	LIF	0.03125	36159840
antineoplastic agents immunological/therapeutic use	MTOR	0.03125	34987517
gastrointestinal neoplasms/drug therapy	HAVCR2	0.010416666666666668	36159840
antineoplastic agents immunological/therapeutic use	PDCD1	0.1651735722284434	36159840
antineoplastic agents immunological/therapeutic use	PDCD1	0.1651735722284434	34987517
gastrointestinal neoplasms/drug therapy	IL15	0.010416666666666668	36159840
gastrointestinal neoplasms/drug therapy	IL17C	0.010416666666666668	36159840
gastrointestinal neoplasms/drug therapy	IL21	0.010416666666666668	36159840
gastrointestinal neoplasms/drug therapy	IL22	0.020833333333333332	36159840
gastrointestinal neoplasms/drug therapy	IL4	0.010416666666666668	36159840
gastrointestinal neoplasms/drug therapy	IL6	0.020833333333333332	36159840
graft vs host disease/immunology	CD4	0.020833333333333332	34338882
gastrointestinal neoplasms/drug therapy	LIF	0.010416666666666668	36159840
graft vs host disease/immunology	CD68	0.020833333333333332	34338882
graft vs host disease/immunology	CD8A	0.05208333333333334	34338882
gastrointestinal neoplasms/drug therapy	PDCD1	0.26041666666666663	36159840
immunocompromised host	prednisone/therapeutic use	0.010416666666666668	34956219
gastrointestinal tract/metabolism	b7-h1 antigen/metabolism	0.010416666666666668	32298485
ACAD8	CRP	0.020833333333333336	32418993
gastrointestinal tract/metabolism	CD274	0.15624999999999997	32298485
ACAD8	PDCD1	0.45504385964912286	33506015
gastrointestinal tract/metabolism	PDCD1	0.26041666666666663	32298485
ligands	CD274	0.15624999999999997	35432346
ligands	CTLA4	0.125	35432346
immune checkpoint inhibitors/pharmacology	inflammatory bowel diseases	0.08201754385964913	32298485
ligands	PDCD1	0.26041666666666663	35432346
immune checkpoint inhibitors/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.2980379053329963	33506015
immune checkpoint inhibitors/pharmacology	melanoma/complications	0.12108062709966406	32404733
immune checkpoint inhibitors/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.041666666666666664	33506015
colon/immunology	t-lymphocyte subsets/immunology	0.020833333333333336	34777387
cd8-positive t-lymphocytes/immunology	cytotoxicity immunologic	0.010416666666666668	34987517
immune checkpoint inhibitors/pharmacology	gastrointestinal tract/metabolism	0.041666666666666664	32298485
AHR	IL22	0.020833333333333332	35236743
cd8-positive t-lymphocytes/immunology	CD8A	0.05208333333333334	34987517
immune checkpoint inhibitors/pharmacology	b7-h1 antigen/metabolism	0.041666666666666664	32298485
cd8-positive t-lymphocytes/immunology	MTOR	0.010416666666666668	34987517
immune checkpoint inhibitors/pharmacology	ACAD8	0.08201754385964913	33506015
immune checkpoint inhibitors/pharmacology	AHR	0.041666666666666664	35236743
cd8-positive t-lymphocytes/immunology	PDCD1	0.26041666666666663	34987517
immune checkpoint inhibitors/pharmacology	CD274	0.49916916519163396	32298485
immune checkpoint inhibitors/pharmacology	IL22	0.08201754385964913	35236743
APC	ARG1	0.020833333333333336	33495297
immune checkpoint inhibitors/pharmacology	PDCD1	0.052965719033341754	32298485
immune checkpoint inhibitors/pharmacology	PDCD1	0.052965719033341754	32404733
immune checkpoint inhibitors/pharmacology	PDCD1	0.052965719033341754	33506015
APC	CD274	0.2894736842105262	33462141
APC	CD8A	0.10197368421052633	33462141
melanoma/complications	ctla-4 antigen/antagonists & inhibitors	0.09178331466965287	32567084
APC	IL17A	0.041447368421052636	33462141
melanoma/complications	infliximab/administration & dosage	0.03125	32418993
hepatitis autoimmune/etiology	myasthenia gravis/chemically induced	0.010416666666666668	32130969
melanoma/complications	antineoplastic agents immunological/adverse effects	0.20517917133258673	32567084
hepatitis autoimmune/etiology	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
APC	MIR15B	0.020833333333333336	33462141
APC	NRF1	0.020833333333333336	33462141
APC	PARP1	0.020833333333333336	33495297
APC	PDCD1	0.06578947368421052	33495297
APC	PDCD1	0.06578947368421052	33462141
melanoma/complications	ACAD8	0.06184210526315789	32418993
APC	TIPARP	0.020833333333333336	33495297
hepatitis autoimmune/etiology	ipilimumab/therapeutic use	0.03125	32130969
melanoma/complications	CRP	0.03125	32418993
melanoma/complications	CTLA4	0.33311870100783875	32567084
dose-response relationship drug	leukocyte l1 antigen complex/analysis	0.09178331466965287	21694533
dose-response relationship drug	programmed cell death 1 receptor/antagonists & inhibitors	0.23197088465845458	32540858
melanoma/complications	PDCD1	0.1651735722284434	32567084
melanoma/complications	PDCD1	0.1651735722284434	32404733
cell line tumor	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.020833333333333336	33495297
cell line tumor	cd8-positive t-lymphocytes/immunology	0.020833333333333336	34987517
ARG1	PARP1	0.010416666666666668	33495297
ARG1	PDCD1	0.26041666666666663	33495297
dose-response relationship drug	drugs investigational/administration & dosage	0.03125	32540858
ARG1	TIPARP	0.010416666666666668	33495297
dose-response relationship drug	steroids/therapeutic use	0.06184210526315789	33290513
cell line tumor	piperazines/administration & dosage	0.020833333333333336	33495297
cell line tumor	cytotoxicity immunologic	0.020833333333333336	34987517
cell line tumor	APC	0.041447368421052636	33495297
cell line tumor	ARG1	0.020833333333333336	33495297
dose-response relationship drug	CD274	0.40285554311310195	32540858
antineoplastic agents immunological/adverse effects	anti-bacterial agents/pharmacology	0.07291666666666667	34162429
BTLA	CD274	0.15624999999999997	36159840
cell line tumor	CD8A	0.10197368421052633	34987517
BTLA	CD28	0.010416666666666668	36159840
antineoplastic agents immunological/adverse effects	CD274	0.7082674345737221	32702598
BTLA	CSF2	0.010416666666666668	36159840
antineoplastic agents immunological/adverse effects	CTLA4	0.21075657434135167	32567084
antineoplastic agents immunological/adverse effects	CTLA4	0.21075657434135167	32702598
BTLA	HAVCR2	0.010416666666666668	36159840
BTLA	IL15	0.010416666666666668	36159840
cell line tumor	MTOR	0.020833333333333336	34987517
BTLA	IL17C	0.010416666666666668	36159840
cell line tumor	PARP1	0.020833333333333336	33495297
BTLA	IL21	0.010416666666666668	36159840
cell line tumor	PDCD1	0.06578947368421052	33495297
cell line tumor	PDCD1	0.06578947368421052	34987517
BTLA	IL22	0.020833333333333332	36159840
antineoplastic agents immunological/adverse effects	PDCD1	0.5880286614852955	32567084
antineoplastic agents immunological/adverse effects	PDCD1	0.5880286614852955	32702598
dose-response relationship drug	PDCD1	0.5999790033594625	32540858
antineoplastic agents immunological/adverse effects	SNCA	0.20517917133258676	33476895
BTLA	IL4	0.010416666666666668	36159840
cell line tumor	TIPARP	0.020833333333333336	33495297
BTLA	IL6	0.020833333333333332	36159840
BTLA	LIF	0.010416666666666668	36159840
BTLA	PDCD1	0.26041666666666663	36159840
dose-response relationship drug	diarrhea/etiology	0.03125	21694533
dose-response relationship drug	gastrointestinal hemorrhage/etiology	0.03125	21694533
dose-response relationship drug	prednisolone/administration & dosage	0.03125	21694533
dose-response relationship drug	glucocorticoids/administration & dosage	0.03125	21694533
dose-response relationship drug	abdominal pain/etiology	0.03125	21694533
neutrophils/drug effects	antibodies monoclonal/adverse effects	0.010416666666666668	32567084
neutrophils/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32567084
CD274	CD28	0.15625000000000003	36159840
CD274	CD4	0.28947368421052627	33555016
CD274	CD68	0.28947368421052627	33555016
neutrophils/drug effects	melanoma/complications	0.03125	32567084
CD274	CD8A	0.1725403598818299	33555016
CD274	CD8A	0.1725403598818299	33462141
CD274	CSF2	0.15625000000000003	36159840
neutrophils/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03125	32567084
CD274	CTLA4	0.00028177819268363754	34992611
CD274	CTLA4	0.00028177819268363754	32702598
CD274	CTLA4	0.00028177819268363754	33555016
CD274	CTLA4	0.00028177819268363754	35917654
CD274	CTLA4	0.00028177819268363754	35432346
CD274	CTLA4	0.00028177819268363754	32934876
CD274	CTLA4	0.00028177819268363754	33314269
CD274	HAVCR2	0.15625000000000003	36159840
adenocarcinoma of lung/drug therapy	CD274	0.15624999999999997	32389505
CD274	IL15	0.15625000000000003	36159840
CD274	IL17A	0.28947368421052627	33462141
CD274	IL17C	0.15625000000000003	36159840
CD274	IL21	0.15625000000000003	36159840
CD274	IL22	0.28947368421052627	36159840
CD274	IL4	0.15625000000000003	36159840
neutrophils/drug effects	antineoplastic agents immunological/adverse effects	0.07291666666666667	32567084
CD274	IL6	0.28947368421052627	36159840
CD274	LIF	0.15625000000000003	36159840
CD274	MIR15B	0.15625000000000003	33462141
CD274	NRF1	0.15625000000000003	33462141
CD274	PDCD1	1.012304913553398e-07	36159840
CD274	PDCD1	1.012304913553398e-07	34992611
CD274	PDCD1	1.012304913553398e-07	32702598
CD274	PDCD1	1.012304913553398e-07	33555016
CD274	PDCD1	1.012304913553398e-07	33173388
CD274	PDCD1	1.012304913553398e-07	33462141
CD274	PDCD1	1.012304913553398e-07	34158318
CD274	PDCD1	1.012304913553398e-07	32960847
CD274	PDCD1	1.012304913553398e-07	32298485
CD274	PDCD1	1.012304913553398e-07	35917654
CD274	PDCD1	1.012304913553398e-07	32540858
CD274	PDCD1	1.012304913553398e-07	33314269
CD274	PDCD1	1.012304913553398e-07	35432346
CD274	SNCA	0.402855543113102	32934876
neutrophils/drug effects	CTLA4	0.125	32567084
CD28	CSF2	0.010416666666666668	36159840
CD28	HAVCR2	0.010416666666666668	36159840
CD28	IL15	0.010416666666666668	36159840
neutrophils/drug effects	PDCD1	0.26041666666666663	32567084
CD28	IL17C	0.010416666666666668	36159840
trinitrobenzenesulfonic acid/adverse effects	ACAD8	0.020833333333333332	33506015
CD28	IL21	0.010416666666666668	36159840
CD28	IL22	0.020833333333333332	36159840
CD28	IL4	0.010416666666666668	36159840
CD28	IL6	0.020833333333333332	36159840
CD28	LIF	0.010416666666666668	36159840
CD28	PDCD1	0.26041666666666663	36159840
trinitrobenzenesulfonic acid/adverse effects	PDCD1	0.26041666666666663	33506015
myasthenia gravis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.020833333333333332	32130969
cd8-positive t-lymphocytes/drug effects	phenotype	0.0002192982456140351	34338882
cd8-positive t-lymphocytes/drug effects	phenotype	0.0002192982456140351	34147519
cd8-positive t-lymphocytes/drug effects	CD4	0.041447368421052636	34338882
CD4	CD68	0.0002192982456140351	33555016
CD4	CD68	0.0002192982456140351	34338882
cd8-positive t-lymphocytes/drug effects	CD68	0.041447368421052636	34338882
CD4	CD8A	0.002192982456140351	33555016
CD4	CD8A	0.002192982456140351	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.002192982456140351	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.002192982456140351	34147519
chemokines/metabolism	multigene family	0.010416666666666668	32603654
cd8-positive t-lymphocytes/drug effects	CTLA4	0.23552631578947367	34147519
CD4	CTLA4	0.23552631578947367	33555016
myasthenia gravis/chemically induced	ipilimumab/therapeutic use	0.03125	32130969
cd8-positive t-lymphocytes/drug effects	PDCD1	0.45504385964912286	34147519
CD4	PDCD1	0.45504385964912286	33555016
chemokines/metabolism	CTLA4	0.125	32603654
chemokines/metabolism	PDCD1	0.26041666666666663	32603654
drugs investigational/administration & dosage	CD274	0.15624999999999997	32540858
CD68	CD8A	0.002192982456140351	33555016
CD68	CD8A	0.002192982456140351	34338882
CD68	CTLA4	0.23552631578947367	33555016
drugs investigational/administration & dosage	PDCD1	0.26041666666666663	32540858
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.013325867861142216	32567084
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.013325867861142216	32702598
ctla-4 antigen/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.06184210526315789	34147519
ctla-4 antigen/antagonists & inhibitors	phenotype	0.06184210526315789	34147519
CD68	PDCD1	0.45504385964912286	33555016
ctla-4 antigen/antagonists & inhibitors	CD274	0.40285554311310195	32702598
ctla-4 antigen/antagonists & inhibitors	CD8A	0.1497410414333707	34147519
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0015397536394176929	32567084
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0015397536394176929	32702598
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0015397536394176929	34147519
antibodies monoclonal/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08333333333333333	32567084
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.016097424412094063	32567084
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.016097424412094063	32702598
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.016097424412094063	34147519
antibodies monoclonal/adverse effects	melanoma/complications	0.03125	32567084
CD8A	CTLA4	0.11612506655316639	33555016
CD8A	CTLA4	0.11612506655316639	34147519
biomarkers/analysis	antineoplastic agents/adverse effects	0.03125	26448188
biomarkers/analysis	intestinal mucosa/chemistry	0.03125	26448188
biomarkers/analysis	leukemia lymphocytic chronic b-cell/drug therapy	0.03125	26448188
antibodies monoclonal/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.03125	32567084
biomarkers/analysis	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.03125	26448188
biomarkers/analysis	purines/adverse effects	0.03125	26448188
biomarkers/analysis	colon/chemistry	0.03125	26448188
CD8A	IL17A	0.10197368421052633	33462141
biomarkers/analysis	lymphocytosis/chemically induced	0.03125	26448188
biomarkers/analysis	protein kinase inhibitors/adverse effects	0.03125	26448188
biomarkers/analysis	apoptosis/drug effects	0.03125	26448188
biomarkers/analysis	quinazolinones/adverse effects	0.03125	26448188
biomarkers/analysis	lymphoma non-hodgkin/drug therapy	0.03125	26448188
biomarkers/analysis	PIK3CD	0.03125	26448188
CD8A	MIR15B	0.05208333333333335	33462141
biomarkers/analysis	diarrhea/diagnosis	0.03125	36591847
CD8A	MTOR	0.05208333333333335	34987517
biomarkers/analysis	colitis microscopic/diagnosis	0.03125	36591847
CD8A	NRF1	0.05208333333333335	33462141
antibodies monoclonal/adverse effects	antineoplastic agents immunological/adverse effects	0.07291666666666667	32567084
CD8A	PDCD1	0.015563101301641196	33555016
CD8A	PDCD1	0.015563101301641196	34147519
CD8A	PDCD1	0.015563101301641196	34987517
CD8A	PDCD1	0.015563101301641196	33462141
CHI3L1	CXCL8	0.010416666666666668	36096534
antibodies monoclonal/adverse effects	CTLA4	0.125	32567084
CHI3L1	IL17A	0.020833333333333332	36096534
CHI3L1	IL6	0.020833333333333332	36096534
phenotype	CD4	0.041447368421052636	34338882
phenotype	CD68	0.041447368421052636	34338882
antibodies monoclonal/adverse effects	PDCD1	0.26041666666666663	32567084
phenotype	CD8A	0.002192982456140351	34338882
phenotype	CD8A	0.002192982456140351	34147519
phenotype	CTLA4	0.23552631578947367	34147519
phenotype	PDCD1	0.45504385964912286	34147519
colitis/etiology	immune checkpoint inhibitors/therapeutic use	0.041447368421052636	34987517
colitis/etiology	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34987517
colitis/etiology	cell line tumor	0.041447368421052636	34987517
colitis/etiology	cd8-positive t-lymphocytes/immunology	0.020833333333333336	34987517
colitis/etiology	antineoplastic agents immunological/adverse effects	0.14122807017543856	34162429
multigene family	CTLA4	0.125	32603654
CSF2	HAVCR2	0.010416666666666668	36159840
colitis/etiology	anti-bacterial agents/pharmacology	0.020833333333333336	34162429
CSF2	IL15	0.010416666666666668	36159840
CSF2	IL17C	0.010416666666666668	36159840
colitis/etiology	cytotoxicity immunologic	0.020833333333333336	34987517
b7-h1 antigen/metabolism	CD274	0.15624999999999997	32298485
CSF2	IL21	0.010416666666666668	36159840
CSF2	IL22	0.020833333333333332	36159840
CSF2	IL4	0.010416666666666668	36159840
multigene family	PDCD1	0.26041666666666663	32603654
CSF2	IL6	0.020833333333333332	36159840
CSF2	LIF	0.010416666666666668	36159840
colitis/etiology	CD8A	0.10197368421052633	34987517
CSF2	PDCD1	0.26041666666666663	36159840
b7-h1 antigen/metabolism	PDCD1	0.26041666666666663	32298485
colitis/etiology	MTOR	0.020833333333333336	34987517
poly(adp-ribose) polymerase inhibitors/administration & dosage	piperazines/administration & dosage	0.010416666666666668	33495297
colitis/etiology	PDCD1	0.45504385964912286	34987517
CTLA4	CXCL10	0.12500000000000003	35977003
poly(adp-ribose) polymerase inhibitors/administration & dosage	APC	0.020833333333333332	33495297
inflammatory bowel diseases/complications	CD274	0.2894736842105262	34158318
poly(adp-ribose) polymerase inhibitors/administration & dosage	ARG1	0.010416666666666668	33495297
CTLA4	CXCL9	0.12500000000000003	35977003
inflammatory bowel diseases/complications	PDCD1	0.06578947368421052	32401685
inflammatory bowel diseases/complications	PDCD1	0.06578947368421052	34158318
poly(adp-ribose) polymerase inhibitors/administration & dosage	PARP1	0.010416666666666668	33495297
CTLA4	PDCD1	5.149541243449557e-07	34992611
CTLA4	PDCD1	5.149541243449557e-07	32702598
CTLA4	PDCD1	5.149541243449557e-07	32603654
CTLA4	PDCD1	5.149541243449557e-07	33555016
CTLA4	PDCD1	5.149541243449557e-07	35977003
CTLA4	PDCD1	5.149541243449557e-07	32567084
CTLA4	PDCD1	5.149541243449557e-07	35917654
CTLA4	PDCD1	5.149541243449557e-07	35191192
CTLA4	PDCD1	5.149541243449557e-07	35432346
CTLA4	PDCD1	5.149541243449557e-07	33314269
CTLA4	PDCD1	5.149541243449557e-07	34147519
poly(adp-ribose) polymerase inhibitors/administration & dosage	PDCD1	0.26041666666666663	33495297
CTLA4	SNCA	0.3331187010078388	32934876
poly(adp-ribose) polymerase inhibitors/administration & dosage	TIPARP	0.010416666666666668	33495297
CTLA4	TCIM	0.12500000000000003	35977003
CTLA4	TNF	0.3331187010078388	35977003
gastritis/complications	enterocolitis/chemically induced	0.020833333333333332	36377339
immunosuppressive agents/pharmacology	mucositis/chemically induced	0.010416666666666668	32414860
CXCL10	CXCL9	0.010416666666666668	35977003
CXCL10	PDCD1	0.26041666666666663	35977003
CXCL10	TCIM	0.010416666666666668	35977003
CXCL10	TNF	0.03125	35977003
rna	CTLA4	0.125	35977003
rna	CXCL10	0.010416666666666668	35977003
rna	CXCL9	0.010416666666666668	35977003
CXCL8	IL17A	0.020833333333333332	36096534
rna	PDCD1	0.26041666666666663	35977003
CXCL8	IL6	0.020833333333333332	36096534
rna	TCIM	0.010416666666666668	35977003
rna	TNF	0.03125	35977003
infliximab/administration & dosage	ACAD8	0.020833333333333332	32418993
infliximab/administration & dosage	CRP	0.010416666666666668	32418993
immune checkpoint inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16052631578947366	34987517
immune checkpoint inhibitors/therapeutic use	cell line tumor	0.041447368421052636	34987517
CXCL9	PDCD1	0.26041666666666663	35977003
CXCL9	TCIM	0.010416666666666668	35977003
CXCL9	TNF	0.03125	35977003
immune checkpoint inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.020833333333333336	34987517
immune checkpoint inhibitors/therapeutic use	ipilimumab/therapeutic use	0.0618421052631579	32130969
HAVCR2	IL15	0.010416666666666668	36159840
immune checkpoint inhibitors/therapeutic use	cytotoxicity immunologic	0.020833333333333336	34987517
HAVCR2	IL17C	0.010416666666666668	36159840
HAVCR2	IL21	0.010416666666666668	36159840
HAVCR2	IL22	0.020833333333333332	36159840
HAVCR2	IL4	0.010416666666666668	36159840
HAVCR2	IL6	0.020833333333333332	36159840
HAVCR2	LIF	0.010416666666666668	36159840
immune checkpoint inhibitors/therapeutic use	CD8A	0.10197368421052633	34987517
HAVCR2	PDCD1	0.26041666666666663	36159840
immune checkpoint inhibitors/therapeutic use	MTOR	0.020833333333333336	34987517
immune checkpoint inhibitors/therapeutic use	PDCD1	0.45504385964912286	34987517
piperazines/administration & dosage	APC	0.020833333333333332	33495297
piperazines/administration & dosage	ARG1	0.010416666666666668	33495297
IL15	IL17C	0.010416666666666668	36159840
IL15	IL21	0.010416666666666668	36159840
IL15	IL22	0.020833333333333332	36159840
IL15	IL4	0.010416666666666668	36159840
IL15	IL6	0.020833333333333332	36159840
IL15	LIF	0.010416666666666668	36159840
IL15	PDCD1	0.26041666666666663	36159840
piperazines/administration & dosage	PARP1	0.010416666666666668	33495297
piperazines/administration & dosage	PDCD1	0.26041666666666663	33495297
piperazines/administration & dosage	TIPARP	0.010416666666666668	33495297
IL17A	IL6	0.041447368421052636	36096534
leukocyte l1 antigen complex/analysis	biomarkers/analysis	0.001959686450167973	36591847
leukocyte l1 antigen complex/analysis	biomarkers/analysis	0.001959686450167973	33436487
IL17A	MIR15B	0.020833333333333336	33462141
IL17A	NRF1	0.020833333333333336	33462141
IL17A	PDCD1	0.45504385964912286	33462141
IL17C	IL21	0.010416666666666668	36159840
IL17C	IL22	0.020833333333333332	36159840
IL17C	IL4	0.010416666666666668	36159840
IL17C	IL6	0.020833333333333332	36159840
IL17C	LIF	0.010416666666666668	36159840
IL17C	PDCD1	0.26041666666666663	36159840
leukocyte l1 antigen complex/analysis	diarrhea/etiology	0.03125	21694533
leukocyte l1 antigen complex/analysis	gastrointestinal hemorrhage/etiology	0.03125	21694533
leukocyte l1 antigen complex/analysis	prednisolone/administration & dosage	0.03125	21694533
leukocyte l1 antigen complex/analysis	glucocorticoids/administration & dosage	0.03125	21694533
leukocyte l1 antigen complex/analysis	diarrhea/diagnosis	0.03125	36591847
IL21	IL22	0.020833333333333332	36159840
leukocyte l1 antigen complex/analysis	abdominal pain/etiology	0.03125	21694533
IL21	IL4	0.010416666666666668	36159840
leukocyte l1 antigen complex/analysis	colitis microscopic/diagnosis	0.03125	36591847
IL21	IL6	0.020833333333333332	36159840
IL21	LIF	0.010416666666666668	36159840
IL21	PDCD1	0.26041666666666663	36159840
IL22	IL4	0.020833333333333336	36159840
IL22	IL6	0.041447368421052636	36159840
IL22	LIF	0.020833333333333336	36159840
IL22	PDCD1	0.45504385964912286	36159840
IL4	IL6	0.020833333333333332	36159840
IL4	LIF	0.010416666666666668	36159840
IL4	PDCD1	0.26041666666666663	36159840
IL6	LIF	0.020833333333333336	36159840
IL6	PDCD1	0.45504385964912286	36159840
LIF	PDCD1	0.26041666666666663	36159840
MIR15B	NRF1	0.010416666666666668	33462141
MIR15B	PDCD1	0.26041666666666663	33462141
MTOR	PDCD1	0.26041666666666663	34987517
NRF1	PDCD1	0.26041666666666663	33462141
PARP1	PDCD1	0.26041666666666663	33495297
PARP1	TIPARP	0.010416666666666668	33495297
PDCD1	TCIM	0.2604166666666667	35977003
PDCD1	TIPARP	0.2604166666666667	33495297
PDCD1	TNF	0.5999790033594625	35977003
SNCA	TNF	0.09178331466965287	32641348
TCIM	TNF	0.03125	35977003
antineoplastic agents/adverse effects	intestinal mucosa/chemistry	0.010416666666666668	26448188
antineoplastic agents/adverse effects	leukemia lymphocytic chronic b-cell/drug therapy	0.010416666666666668	26448188
antineoplastic agents/adverse effects	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010416666666666668	26448188
antineoplastic agents/adverse effects	purines/adverse effects	0.010416666666666668	26448188
antineoplastic agents/adverse effects	colon/chemistry	0.010416666666666668	26448188
antineoplastic agents/adverse effects	lymphocytosis/chemically induced	0.010416666666666668	26448188
antineoplastic agents/adverse effects	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
antineoplastic agents/adverse effects	apoptosis/drug effects	0.010416666666666668	26448188
antineoplastic agents/adverse effects	quinazolinones/adverse effects	0.010416666666666668	26448188
antineoplastic agents/adverse effects	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
antineoplastic agents/adverse effects	PIK3CD	0.010416666666666668	26448188
intestinal mucosa/chemistry	leukemia lymphocytic chronic b-cell/drug therapy	0.010416666666666668	26448188
intestinal mucosa/chemistry	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010416666666666668	26448188
intestinal mucosa/chemistry	purines/adverse effects	0.010416666666666668	26448188
intestinal mucosa/chemistry	colon/chemistry	0.010416666666666668	26448188
intestinal mucosa/chemistry	lymphocytosis/chemically induced	0.010416666666666668	26448188
intestinal mucosa/chemistry	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
intestinal mucosa/chemistry	apoptosis/drug effects	0.010416666666666668	26448188
intestinal mucosa/chemistry	quinazolinones/adverse effects	0.010416666666666668	26448188
intestinal mucosa/chemistry	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
intestinal mucosa/chemistry	PIK3CD	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	purines/adverse effects	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	colon/chemistry	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	lymphocytosis/chemically induced	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	apoptosis/drug effects	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	quinazolinones/adverse effects	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
leukemia lymphocytic chronic b-cell/drug therapy	PIK3CD	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	purines/adverse effects	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	colon/chemistry	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphocytosis/chemically induced	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	apoptosis/drug effects	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	quinazolinones/adverse effects	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	PIK3CD	0.010416666666666668	26448188
purines/adverse effects	colon/chemistry	0.010416666666666668	26448188
purines/adverse effects	lymphocytosis/chemically induced	0.010416666666666668	26448188
purines/adverse effects	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
purines/adverse effects	apoptosis/drug effects	0.010416666666666668	26448188
purines/adverse effects	quinazolinones/adverse effects	0.010416666666666668	26448188
purines/adverse effects	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
purines/adverse effects	PIK3CD	0.010416666666666668	26448188
colon/chemistry	lymphocytosis/chemically induced	0.010416666666666668	26448188
colon/chemistry	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
colon/chemistry	apoptosis/drug effects	0.010416666666666668	26448188
colon/chemistry	quinazolinones/adverse effects	0.010416666666666668	26448188
colon/chemistry	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
colon/chemistry	PIK3CD	0.010416666666666668	26448188
lymphocytosis/chemically induced	protein kinase inhibitors/adverse effects	0.010416666666666668	26448188
lymphocytosis/chemically induced	apoptosis/drug effects	0.010416666666666668	26448188
lymphocytosis/chemically induced	quinazolinones/adverse effects	0.010416666666666668	26448188
lymphocytosis/chemically induced	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
lymphocytosis/chemically induced	PIK3CD	0.010416666666666668	26448188
protein kinase inhibitors/adverse effects	apoptosis/drug effects	0.010416666666666668	26448188
protein kinase inhibitors/adverse effects	quinazolinones/adverse effects	0.010416666666666668	26448188
protein kinase inhibitors/adverse effects	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
protein kinase inhibitors/adverse effects	PIK3CD	0.010416666666666668	26448188
apoptosis/drug effects	quinazolinones/adverse effects	0.010416666666666668	26448188
apoptosis/drug effects	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
apoptosis/drug effects	PIK3CD	0.010416666666666668	26448188
quinazolinones/adverse effects	lymphoma non-hodgkin/drug therapy	0.010416666666666668	26448188
quinazolinones/adverse effects	PIK3CD	0.010416666666666668	26448188
lymphoma non-hodgkin/drug therapy	PIK3CD	0.010416666666666668	26448188
diarrhea/etiology	gastrointestinal hemorrhage/etiology	0.010416666666666668	21694533
diarrhea/etiology	prednisolone/administration & dosage	0.010416666666666668	21694533
diarrhea/etiology	glucocorticoids/administration & dosage	0.010416666666666668	21694533
diarrhea/etiology	abdominal pain/etiology	0.010416666666666668	21694533
gastrointestinal hemorrhage/etiology	prednisolone/administration & dosage	0.010416666666666668	21694533
gastrointestinal hemorrhage/etiology	glucocorticoids/administration & dosage	0.010416666666666668	21694533
gastrointestinal hemorrhage/etiology	abdominal pain/etiology	0.010416666666666668	21694533
prednisolone/administration & dosage	glucocorticoids/administration & dosage	0.010416666666666668	21694533
prednisolone/administration & dosage	abdominal pain/etiology	0.010416666666666668	21694533
glucocorticoids/administration & dosage	abdominal pain/etiology	0.010416666666666668	21694533
diarrhea/diagnosis	colitis microscopic/diagnosis	0.010416666666666668	36591847
